Document and Entity Information
Document and Entity Information - USD ($) | Jan. 01, 2018 | Dec. 31, 2018 | Feb. 15, 2019 | Jun. 29, 2018 |
Document and Entity Information | ||||
Entity Registrant Name | VEECO INSTRUMENTS INC | |||
Entity Central Index Key | 0000103145 | |||
Document Type | 10-K/A | |||
Document Period End Date | Dec. 31, 2018 | |||
Amendment Flag | true | |||
Amendment Description | This Amendment No. 1 to Form 10-K (this “Amendment”) amends the Annual Report on Form 10-K for the fiscal year ended December 31, 2018, originally filed on February 25, 2019 (the “Original 10-K”), of Veeco Instruments Inc., a Delaware corporation (the “Company” or “we”). We are filing this Amendment solely to correct an inadvertent clerical error on the cover page of the Original 10-K in which the box identifying the Company as an accelerated filer was incorrectly checked. The clerical error has been corrected in this Amendment by checking the “Large accelerated filer” box on the cover page. This Amendment does not reflect events occurring after February 25, 2019 or otherwise modify or update the disclosures set forth in the Original 10-K, including the financial statements and notes thereto included in the Original 10-K. | |||
Current Fiscal Year End Date | --12-31 | |||
Entity Well-known Seasoned Issuer | Yes | |||
Entity Voluntary Filers | No | |||
Entity Current Reporting Status | Yes | |||
Entity Filer Category | Large Accelerated Filer | |||
Entity Public Float | $ 682,511,019 | |||
Entity Common Stock, Shares Outstanding | 48,038,565 | |||
Entity Small Business | false | |||
Entity Emerging Growth Company | false | |||
Entity Shell Company | false | |||
Document Fiscal Year Focus | 2018 | |||
Document Fiscal Period Focus | FY |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Current assets: | ||
Cash and cash equivalents | $ 212,273 | $ 279,736 |
Restricted cash | 809 | 847 |
Short-term investments | 48,189 | 47,780 |
Accounts receivable, net | 66,808 | 98,866 |
Contract assets | 10,397 | 160 |
Inventories | 156,311 | 120,266 |
Deferred cost of sales | 3,072 | 15,994 |
Prepaid expenses and other current assets | 22,221 | 33,437 |
Total current assets | 520,080 | 597,086 |
Property, plant, and equipment, net | 80,284 | 85,058 |
Intangible assets, net | 85,149 | 369,843 |
Goodwill | 184,302 | 307,131 |
Deferred income taxes | 1,869 | 3,047 |
Other assets | 29,132 | 25,310 |
Total assets | 900,816 | 1,387,475 |
Current liabilities: | ||
Accounts payable | 39,611 | 50,318 |
Accrued expenses and other current liabilities | 46,450 | 58,068 |
Customer deposits and deferred revenue | 72,736 | 112,032 |
Income taxes payable | 1,256 | 3,846 |
Total current liabilities | 160,053 | 224,264 |
Deferred income taxes | 5,690 | 36,845 |
Long-term debt | 287,392 | 275,630 |
Other liabilities | 9,906 | 10,643 |
Total liabilities | 463,041 | 547,382 |
Stockholders' equity: | ||
Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding. | ||
Common stock, $0.01 par value; 120,000,000 shares authorized; 48,547,417 and 48,229,251 shares issued at December 31, 2018 and December 31, 2017, respectively; 48,024,685 and 48,144,416 shares outstanding at December 31, 2018 and December 31, 2017, respectively. | 485 | 482 |
Additional paid-in capital | 1,061,325 | 1,051,953 |
Accumulated deficit | (619,983) | (212,870) |
Accumulated other comprehensive income | 1,820 | 1,812 |
Treasury stock, at cost, 522,732 and 84,835 shares at December 31, 2018 and December 31, 2017, respectively. | (5,872) | (1,284) |
Total stockholders' equity | 437,775 | 840,093 |
Total liabilities and stockholders' equity | $ 900,816 | $ 1,387,475 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2018 | Dec. 31, 2017 |
Consolidated Balance Sheets | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized | 500,000 | 500,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, authorized shares | 120,000,000 | 120,000,000 |
Common stock, shares issued | 48,547,417 | 48,229,251 |
Common stock, shares outstanding | 48,024,685 | 48,144,416 |
Treasury stock, shares | 522,732 | 84,835 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Consolidated Statements of Operations | |||
Net sales | $ 542,082 | $ 475,686 | $ 331,702 |
Cost of sales | 348,363 | 299,458 | 198,604 |
Gross profit | 193,719 | 176,228 | 133,098 |
Operating expenses, net: | |||
Research and development | 97,755 | 81,987 | 81,016 |
Selling, general, and administrative | 92,060 | 100,250 | 77,642 |
Amortization of intangible assets | 32,351 | 35,475 | 19,219 |
Restructuring | 8,556 | 11,851 | 5,640 |
Acquisition costs | 2,959 | 17,786 | |
Asset impairment | 375,172 | 1,139 | 69,520 |
Other, net | 368 | (392) | 223 |
Total operating expenses, net | 609,221 | 248,096 | 253,260 |
Operating income (loss) | (415,502) | (71,868) | (120,162) |
Interest income | 3,186 | 2,335 | 1,180 |
Interest expense | (21,518) | (19,457) | (222) |
Income (loss) before income taxes | (433,834) | (88,990) | (119,204) |
Income tax expense (benefit) | (26,746) | (37,594) | 2,823 |
Net income (loss) | $ (407,088) | $ (51,396) | $ (122,027) |
Income (loss) per common share: | |||
Basic (in dollars per share) | $ (8.63) | $ (1.16) | $ (3.10) |
Diluted (in dollars per share) | $ (8.63) | $ (1.16) | $ (3.10) |
Weighted average number of shares: | |||
Basic (in shares) | 47,151 | 44,174 | 39,340 |
Diluted (in shares) | 47,151 | 44,174 | 39,340 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Consolidated Statements of Comprehensive Income (Loss) | |||
Net income (loss) | $ (407,088) | $ (51,396) | $ (122,027) |
Available-for-sale securities: | |||
Change in net unrealized gains or losses | 11 | (7) | (6) |
Reclassification adjustments for net (gains) losses included in net income | 18 | ||
Unrealized gain (loss) on available-for-sale securities | 11 | (7) | 12 |
Minimum pension liability: | |||
Reclassification adjustments for net (gains) losses included in net income | 866 | ||
Net changes related to minimum pension liability | 866 | ||
Currency translation adjustments: | |||
Change in currency translation adjustments | 5 | 42 | (19) |
Reclassification adjustments for net (gains) losses included in net income | (8) | (430) | |
Net changes related to currency translation adjustments | (3) | 42 | (449) |
Total other comprehensive income (loss), net of tax | 8 | 35 | 429 |
Total comprehensive income (loss) | $ (407,080) | $ (51,361) | $ (121,598) |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands | Common Stock | Treasury Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Income | Total |
Balance at the beginning of the period at Dec. 31, 2015 | $ 410 | $ (9,222) | $ 767,137 | $ (45,058) | $ 1,348 | $ 714,615 |
Balance (in shares) at Dec. 31, 2015 | 40,996 | 469 | ||||
Increase (Decrease) in Stockholders' Equity | ||||||
Net loss | (122,027) | (122,027) | ||||
Other comprehensive income (loss), net of tax | 429 | 429 | ||||
Share-based compensation expense | 15,741 | 15,741 | ||||
Net issuance under employee stock plans | $ (3) | $ 19,948 | (20,890) | (945) | ||
Net issuance under employee stock plans (in shares) | (281) | (1,072) | ||||
Purchases of common stock | $ (13,035) | (13,035) | ||||
Purchase of common stock (in shares) | 730 | |||||
Balance at the end of the period at Dec. 31, 2016 | $ 407 | $ (2,309) | 763,303 | (161,474) | 1,777 | 601,704 |
Balance (in shares) at Dec. 31, 2016 | 40,715 | 127 | ||||
Increase (Decrease) in Stockholders' Equity | ||||||
Cumulative effect of change in accounting principle | ASU 2016-09 | 1,315 | (1,315) | ||||
Cumulative effect of change in accounting principle | ASU 2014-09, Revenue from Contracts with Customers | 6,926 | 6,926 | ||||
Net loss | (51,396) | (51,396) | ||||
Other comprehensive income (loss), net of tax | 35 | 35 | ||||
Share-based compensation expense | 24,396 | 24,396 | ||||
Net issuance under employee stock plans | $ 3 | $ 4,043 | (9,795) | (5,749) | ||
Net issuance under employee stock plans (in shares) | 313 | (245) | ||||
Stock issuance for business acquisition | $ 72 | 228,800 | 228,872 | |||
Stock issuance for business acquisition (in shares) | 7,201 | |||||
Convertible Senior Notes, equity component | 45,249 | 45,249 | ||||
Purchases of common stock | $ (3,018) | (3,018) | ||||
Purchase of common stock (in shares) | 203 | |||||
Balance at the end of the period at Dec. 31, 2017 | $ 482 | $ (1,284) | 1,051,953 | (212,870) | 1,812 | 840,093 |
Balance (in shares) at Dec. 31, 2017 | 48,229 | 85 | ||||
Increase (Decrease) in Stockholders' Equity | ||||||
Net loss | (407,088) | (407,088) | ||||
Other comprehensive income (loss), net of tax | 8 | 8 | ||||
Share-based compensation expense | 16,074 | 16,074 | ||||
Net issuance under employee stock plans | $ 3 | $ 6,721 | (6,702) | (25) | (3) | |
Net issuance under employee stock plans (in shares) | 318 | (512) | ||||
Purchases of common stock | $ (11,309) | (11,309) | ||||
Purchase of common stock (in shares) | 950 | |||||
Balance at the end of the period at Dec. 31, 2018 | $ 485 | $ (5,872) | $ 1,061,325 | $ (619,983) | $ 1,820 | $ 437,775 |
Balance (in shares) at Dec. 31, 2018 | 48,547 | 523 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Cash Flows from Operating Activities | |||
Net income (loss) | $ (407,088) | $ (51,396) | $ (122,027) |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||
Depreciation and amortization | 49,998 | 50,095 | 32,650 |
Non-cash interest expense | 11,762 | 10,446 | |
Deferred income taxes | (27,620) | (35,363) | 997 |
Share-based compensation expense | 16,074 | 24,396 | 15,741 |
Asset impairment | 375,172 | 1,139 | 69,520 |
Provision for bad debts | 99 | 171 | |
Gain on cumulative translation adjustment | (430) | ||
Changes in operating assets and liabilities: | |||
Accounts receivable and contract assets | 21,821 | 10,240 | (8,880) |
Inventories and deferred cost of sales | (24,678) | 6,244 | (6,106) |
Prepaid expenses and other current assets | 11,216 | (10,204) | 6,726 |
Accounts payable and accrued expenses | (19,672) | 11,308 | (24,474) |
Customer deposits and deferred revenue | (39,296) | 22,446 | 9,770 |
Income taxes receivable and payable, net | (4,800) | 775 | 547 |
Long-term income tax liability | (4,877) | ||
Other, net | (627) | (355) | 1,951 |
Net cash provided by (used in) operating activities | (37,738) | 34,993 | (23,844) |
Cash Flows from Investing Activities | |||
Acquisitions of businesses, net of cash acquired | (2,662) | (401,828) | |
Capital expenditures | (12,654) | (24,272) | (11,479) |
Proceeds from the sale of investments | 90,065 | 348,927 | 152,301 |
Payments for purchases of investments | (93,046) | (282,947) | (103,394) |
Proceeds from held for sale assets | 2,284 | 9,512 | |
Other | (230) | ||
Net cash provided by (used in) investing activities | (18,297) | (357,836) | 46,710 |
Cash Flows from Financing Activities | |||
Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan | 3,064 | 2,992 | 1,656 |
Restricted stock tax withholdings | (3,069) | (8,741) | (2,601) |
Purchases of common stock | (11,457) | (2,869) | (13,349) |
Proceeds from long-term debt borrowings | 335,752 | ||
Principal payments on long-term debt | (1,194) | (340) | |
Net cash provided by (used in) financing activities | (11,462) | 325,940 | (14,634) |
Effect of exchange rate changes on cash and cash equivalents | (4) | 42 | (20) |
Net increase (decrease) in cash, cash equivalents, and restricted cash | (67,501) | 3,139 | 8,212 |
Cash, cash equivalents, and restricted cash - beginning of period | 280,583 | 277,444 | 269,232 |
Cash, cash equivalents, and restricted cash - end of period | 213,082 | 280,583 | 277,444 |
Supplemental Disclosure of Cash Flow Information | |||
Interest paid | 9,708 | 4,675 | 225 |
Income taxes paid | 4,799 | 1,939 | 1,669 |
Non-cash operating and financing activities | |||
Net transfer of inventory to property, plant and equipment | $ 1,479 | $ (97) | $ 1,827 |
Significant Accounting Policies
Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2018 | |
Significant Accounting Policies | |
Significant Accounting Policies | Note 1 — Significant Accounting Policies (a) Description of Business Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” or the “Company”) operates in a single segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices. (b) Basis of Presentation The accompanying audited Consolidated Financial Statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”). The Company reports interim quarters on a 13-week basis ending on the last Sunday of each period, which is determined at the start of each year. The Company’s fourth quarter always ends on the last day of the calendar year, December 31. During 2018 the interim quarters ended on April 1, July 1, and September 30, and during 2017 the interim quarters ended on April 2, July 2, and October 1. The Company reports these interim quarters as March 31, June 30, and September 30 in its interim consolidated financial statements. (c) Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, these estimates may ultimately differ from actual results. Significant items subject to such estimates and assumptions include: (i) stand-alone selling prices for the Company’s products and services; (ii) allowances for doubtful accounts; (iii) inventory obsolescence; (iv) the useful lives and expected future cash flows of property, plant, and equipment and identifiable intangible assets; (v) the fair value of the Company’s reporting unit and related goodwill; (vi) investment valuations and the valuation of derivatives, deferred tax assets, and assets acquired in business combinations; (vii) the recoverability of long-lived assets; (viii) liabilities for product warranty and legal contingencies; (ix) share-based compensation; and (x) income tax uncertainties. Actual results could differ from those estimates. (d) Principles of Consolidation The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Companies acquired during each reporting period are reflected in the results of the Company effective from their respective dates of acquisition through the end of the reporting period. (e) Foreign Currencies Assets and liabilities of the Company’s foreign subsidiaries that operate using functional currencies other than the U.S. dollar are translated using the exchange rates in effect at the balance sheet date. Results of operations are translated using monthly average exchange rates. Adjustments arising from the translation of the foreign currency financial statements of the Company’s subsidiaries into U.S. dollars, including intercompany transactions of a long-term nature, are reported as currency translation adjustments in “Accumulated other comprehensive income” in the Consolidated Balance Sheets. Foreign currency transaction gains or losses are included in “Other, net” in the Consolidated Statements of Operations. (f) Revenue Recognition Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another. When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach. Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met. In certain cases the Company’s contracts with customers contain a billing retention, typically 10% of the sales price, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets. The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement. The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected amortization period is one year or less. The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in cost of services when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue. (g) Warranty Costs The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance by providing labor and parts necessary to repair the systems during the warranty period. The Company accounts for the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of sales” in the Consolidated Statements of Operations. The estimated warranty cost is based on the Company’s historical experience with its systems and regional labor costs. The Company calculates the average service hours by region and parts expense per system utilizing actual service records to determine the estimated warranty charge. The Company updates its warranty estimates on a quarterly basis when the actual product performance or field expense differs from original estimates. (h) Shipping and Handling Costs Shipping and handling costs are expenses incurred to move, package, and prepare the Company’s products for shipment and to move the products to a customer’s designated location. These costs are generally comprised of payments to third-party shippers. Shipping and handling costs are included in “Cost of sales” in the Consolidated Statements of Operations. (i) Research and Development Costs Research and development costs are expensed as incurred and include charges for the development of new technology and the transition of existing technology into new products or services. (j) Advertising Expense The cost of advertising is expensed as incurred and totaled $0.9 million, $0.9 million, and $0.8 million for the years ended December 31, 2018, 2017, and 2016, respectively. (k) Accounting for Share-Based Compensation Share-based awards exchanged for employee services are accounted for under the fair value method. Accordingly, share-based compensation cost is measured at the grant date based on the fair value of the award. The expense for awards is recognized over the employee’s requisite service period (generally the vesting period of the award). The Company has elected to treat awards with only service conditions and with graded vesting as one award. Consequently, the total compensation expense is recognized straight-line over the entire vesting period, so long as the compensation cost recognized at any date at least equals the portion of the grant date fair value of the award that is vested at that date. In addition to stock options, restricted share awards (“RSAs”) and restricted stock units (“RSUs”) with time-based vesting, the Company grants performance share units and awards (“PSUs” and “PSAs”) that have either performance or market conditions. Compensation cost for PSUs and PSAs with performance conditions is recognized over the requisite service period based on the timing and expected level of achievement of the performance targets. A change in the assessment of performance attainment prior to the conclusion of the performance period is recognized in the period of the change in estimate. Compensation cost for PSUs and PSAs with market conditions is recognized over the requisite service period regardless of the expected level of achievement. For all PSUs and PSAs, the number of shares issued to the employee at the conclusion of the service period may vary from the original target based upon the level of attainment of the performance or market conditions. The Company uses the Black-Scholes option-pricing model to compute the estimated fair value of option awards and purchase rights under the Employee Stock Purchase Plan. The Company uses a Monte Carlo simulation to compute the estimated fair value of awards with market conditions. The Black-Scholes model and Monte Carlo simulation include assumptions regarding dividend yields, expected volatility, expected option term, and risk-free interest rates. See Note 15, “Stock Plans,” for additional information. See Note 1(t), “Recently Adopted Accounting Standards,” for additional information concerning the Company’s adoption of Accounting Standards Update (“ASU”) 2016-09: Stock Compensation: Improvements to Employee Share-Based Payment Accounting . (l) Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rate is recognized in income in the period that includes the enactment date. On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “2017 Tax Act”), which made broad and complex changes to the U.S. tax code. In response to the 2017 Tax Act, the SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) which provided guidance on accounting for the tax effects of 2017 Tax Act, including addressing any uncertainty or diversity of view in applying ASC 740, Income Taxes (“ASC 740”), in the reporting period in which the 2017 Tax Act was enacted. In addition, SAB 118 provided a measurement period that should not extend beyond one year from the 2017 Tax Act enactment date for companies to complete the accounting under ASC 740. During the year ended December 31, 2018, the Company finalized the accounting for the tax effects of 2017 Tax Act. In January 2018, the FASB released guidance on the accounting for taxes under the global intangible low-taxed income (“GILTI”) provisions of the 2017 Tax Act. The GILTI provisions impose a tax on foreign income in excess of a deemed return on tangible assets of foreign operations. The Company has made a policy election to account for income taxes incurred under GILTI as a period cost. (m) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, investments, derivative financial instruments used in hedging activities, and accounts receivable. The Company invests in a variety of financial instruments and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material credit losses on its investments. The Company maintains an allowance reserve for potentially uncollectible accounts for estimated losses resulting from the inability of its customers to make required payments. The Company evaluates its allowance for doubtful accounts based on a combination of factors. In circumstances where specific invoices are deemed to be uncollectible, the Company provides a specific allowance for bad debt against the amount due to reduce the net recognized receivable to the amount reasonably expected to be collected. The Company also provides allowances based on its write-off history. The allowance for doubtful accounts totaled $0.3 million at December 31, 2018 and 2017. To further mitigate the Company’s exposure to uncollectable accounts, the Company may request certain customers provide a negotiable irrevocable letter of credit drawn on a reputable financial institution. These irrevocable letters of credit are typically issued to mature between zero and 90 days from the date the documentation requirements are met, typically when a system ships or upon receipt of final acceptance from the customer. The Company, at its discretion, may monetize these letters of credit on a non-recourse basis after they become negotiable but before maturity. The fees associated with the monetization are included in “Selling, general, and administrative” in the Consolidated Statements of Operations and were immaterial for the years ended December 31, 2018, 2017, and 2016. (n) Fair Value of Financial Instruments The carrying amounts of financial instruments, including cash equivalents, accounts receivable, accounts payable, and accrued expenses reflected in the consolidated financial statements approximate fair value due to their short-term maturities. The fair value of debt for footnote disclosure purposes, including current maturities, if any, is estimated using recently quoted market prices of the instrument, or if not available, a discounted cash flow analysis based on the estimated current incremental borrowing rates for similar types of instruments. (o) Cash, Cash Equivalents, and Short-Term Investments All financial instruments purchased with an original maturity of three months or less at the time of purchase are considered cash equivalents. Such items may include liquid money market funds, certificate of deposit and time deposit accounts, U.S. treasuries, government agency securities, and corporate debt. Investments that are classified as cash equivalents are carried at cost, which approximates fair value. The Company’s cash and cash equivalents includes $69.6 million and $76.7 million of cash equivalents at December 31, 2018 and 2017, respectively. A portion of the Company’s cash and cash equivalents is held by its subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar. Approximately 32% and 77% of cash and cash equivalents were maintained outside the United States at December 31, 2018 and 2017, respectively. Marketable debt securities are generally classified as available-for-sale for use in current operations, if required, and are reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income.” These securities can include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other, net” in the Consolidated Statements of Operations. The specific identification method is used to determine the realized gains and losses on investments. Non-marketable equity securities are equity securities without readily observable market prices and are included in “Other assets” in the Consolidated Balance Sheets. Non-marketable securities are measured at cost, adjusted for changes in observable prices minus impairment. Changes in fair value are included in “Other, net” in the Consolidated Statements of Operations. (p) Inventories Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. Estimates of net realizable value include, but are not limited to, management’s forecasts related to the Company’s future manufacturing schedules, customer demand, technological and/or market obsolescence, general market conditions, possible alternative uses, and the ultimate realization of excess inventory. If future customer demand or market conditions are less favorable than the Company’s projections, additional inventory write-downs may be required and would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition. See Note 5, “Business Combinations,” for additional information. (q) Business Combinations The Company allocates the fair value of the purchase consideration of the Company’s acquisitions to the tangible assets, intangible assets, including in-process research and development (“IPR&D”), if any, and liabilities assumed, based on estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. See Note 5, “Business Combinations,” for additional information. (r) Goodwill and Indefinite-Lived Intangible Assets Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is measured as the excess of the consideration transferred over the net fair value of identifiable assets acquired and liabilities assumed. Intangible assets with indefinite useful lives are measured at their respective fair values on the acquisition date. Intangible assets related to IPR&D projects are considered to be indefinite-lived until the completion or abandonment of the associated R&D efforts. If and when development is complete, the associated assets would be deemed long-lived and would then be amortized based on their respective estimated useful lives at that point in time. Goodwill and indefinite-lived intangibles are not amortized into results of operations but instead are evaluated for impairment. The Company performs the evaluation in the beginning of the fourth quarter of each year or more frequently if impairment indicators arise. In testing goodwill for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the reporting unit’s fair value is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the reporting unit to its carrying amount. If the fair value exceeds the carrying amount, goodwill is not impaired. If the carrying amount exceeds fair value, the Company then records an impairment loss equal to the difference, up to the carrying value of goodwill. The Company determines the fair value of its reporting unit based on a reconciliation of the fair value of the reporting unit to the Company’s adjusted market capitalization. The adjusted market capitalization is calculated by multiplying the average share price of the Company’s common stock for the last ten trading days prior to the measurement date by the number of outstanding common shares and adding a control premium. The control premium is estimated using historical transactions in similar industries. In testing indefinite-lived intangible assets for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the indefinite-lived intangible asset to its carrying amount. The Company determines the fair value of its indefinite-lived intangible assets using a discounted cash flow method. (s) Long-Lived Assets Long-lived intangible assets consist of purchased technology, customer relationships, patents, trademarks and tradenames, and backlog and are initially recorded at fair value. Long-lived intangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or straight-lined if such pattern cannot be reliably determined. Property, plant, and equipment are recorded at cost. Depreciation expense is calculated based on the estimated useful lives of the assets by using the straight-line method. Amortization of leasehold improvements is recognized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, a recoverability test is performed utilizing undiscounted cash flows expected to be generated by that asset or asset group compared to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, impairment is recognized to the extent the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models or, when available, quoted market values and third-party appraisals. (t) Recently Adopted Accounting Standards The Company adopted ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”), as of January 1, 2018, using the full retrospective method. All amounts and disclosures set forth in this Form 10-K reflect these changes. The most significant financial statement impacts of adopting ASC 606 are the elimination of the constraint on revenue associated with the billing retention related to the receipt of customer final acceptance and the identification of installation services as a performance obligation. The elimination of the constraint on revenue related to customer final acceptance, which is usually about 10 percent of a system sale, is now generally recognized at the time the Company transfers control of the system to the customer, which is earlier than under the Company’s previous revenue recognition model for certain contracts that were subject to the billing constraint. The performance obligation related to installation services is now recognized as the installation services are performed, which is later than the Company’s previous revenue recognition model. The Company applied ASC 606 retrospectively and elected to use the disclosure exemption in the transition guidance under which the Company does not disclose prior period information regarding the amount of the transaction price allocated to remaining performance obligations. The cumulative effect of the adoption was recognized as a decrease to Accumulated deficit of $6.9 million on January 1, 2016. The following tables summarize the impact of adoption on the Company’s previously reported financial position and results of operations: December 31, 2017 As reported Adjustments As adjusted (in thousands) Balance Sheet Contract assets $ — $ 160 $ 160 Deferred cost of sales 16,060 (66) 15,994 Deferred income taxes 2,953 94 3,047 Accrued expenses and other current liabilities 60,339 (2,271) 58,068 Customer deposits and deferred revenue 108,953 3,079 112,032 Additional paid-in capital 1,053,079 (1,126) 1,051,953 Accumulated deficit (213,376) 506 (212,870) Year ended December 31, 2017 2016 As reported Adjustments As adjusted As reported Adjustments As adjusted (in thousands, except per share amounts) Statement of Operations Net sales $ 484,756 $ (9,070) $ 475,686 $ 332,451 $ (749) $ 331,702 Cost of sales 300,438 (980) 299,458 199,593 (989) 198,604 Income tax expense (benefit) (36,107) (1,487) (37,594) 2,766 57 2,823 Net income (loss) (44,793) (6,603) (51,396) (122,210) 183 (122,027) Diluted earnings (loss) per share (1.01) (0.15) (1.16) (3.11) 0.01 (3.10) The Company’s adoption of the standard had no impact to cash provided by or used in operating, investing, or financing activities on the Consolidated Statements of Cash Flows. The Company adopted ASU 2016-01, Financial Instruments – Overall , as of January 1, 2018. This ASU requires certain equity investments to be measured at fair value, with changes in fair value recognized in net income. The Company measures equity investments without readily observable market prices at cost, adjusted for changes in observable prices minus impairment. Changes in measurement are included in “Other, net” in the Consolidated Statements of Operations. This ASU has not had a material impact on the consolidated financial statements upon adoption, and the Company will monitor its equity investments each reporting period for changes in observable market prices, if any, which may be material in future periods. The Company adopted ASU 2016-09: Stock Compensation: Improvements to Employee Share-Based Payment Accounting , as of January 1, 2016. This ASU simplifies several aspects of the accounting for share-based payments. Beginning in 2016, excess tax benefits and deficiencies are recognized as income tax expense or benefit in the income statement in the reporting period incurred. The Company also made an accounting policy election to account for forfeitures when they occur. The ASU transition guidance requires that this election be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period in which the ASU is adopted. Accordingly, the Company recorded a $1.3 million charge to the opening accumulated deficit balance as of January 1, 2016, with a corresponding adjustment to additional paid-in capital, resulting in no impact to the opening balance of total stockholders’ equity. In addition, the Company recorded additional deferred tax assets with an equally offsetting valuation allowance of $2.4 million. (u) Recent Accounting Pronouncements Not Yet Adopted In February 2016, the FASB issued ASU 2016-02: Leases , which, along with subsequent ASUs related to this topic, has been codified as Accounting Standards Codification 842 (“ASC 842”). ASC 842 generally requires operating lessee rights and obligations to be recognized as assets and liabilities on the balance sheet. The new standard, which is effective for the Company on January 1, 2019, offers a transition option whereby companies can recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption rather than in the earliest period presented. The Company plans to adopt using this transition method. In addition, ASC 842 provides for a number of optional exemptions in transition. The Company expects to elect certain exemptions whereby prior conclusions regarding lease identification, lease classification, and initial direct costs are not required to be reassessed under the new standard. The Company also plans to elect allowable policies whereby the Company will not separate lease and non-lease components, and the Company will not recognize an asset or liability for leases with original terms or renewals of one year or less. Upon adoption, the Company expects to recognize an operating lease liability ranging from $12 million to $16 million based on the present value of remaining minimum rental payments on existing leases, with corresponding assets of approximately the same amount. The Company is also evaluating other pronouncements recently issued but not yet adopted. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements. |
Income (Loss) Per Share
Income (Loss) Per Share | 12 Months Ended |
Dec. 31, 2018 | |
Income (Loss) Per Share | |
Income (Loss) Per Share | Note 2 — Income (Loss) Per Share The Company considers unvested share-based awards that have non-forfeitable rights to dividends prior to vesting to be participating shares, which are treated as a separate class of security from the Company’s common shares for calculating per share data. Therefore, the Company applies the two-class method when calculating income (loss) per share. The two-class method is an earnings allocation formula that determines earnings per share for each class of common stock and participating security according to dividends declared and participation rights in undistributed earnings. However, since the holders of the participating shares are not obligated to fund losses, participating shares are excluded from the calculation of loss per share. Basic income (loss) per share is calculated by dividing net income (loss) by the weighted average number of shares outstanding during the period under the two-class method. Diluted income per share is calculated by dividing net income by the weighted average number of shares used to calculate basic income per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and non-participating share-based awards is considered in diluted income per share by application of the treasury stock method. The dilutive effect of performance share units is included in diluted income per common share in the periods the performance targets have been achieved. The computations of basic and diluted income (loss) per share for the years ended December 31, 2018, 2017, and 2016 are as follows: For the year ended December 31, 2018 2017 2016 (in thousands, except per share amounts) Net income (loss) $ (407,088) $ (51,396) $ (122,027) Net income (loss) per common share: Basic $ (8.63) $ (1.16) $ (3.10) Diluted $ (8.63) $ (1.16) $ (3.10) Basic weighted average shares outstanding 47,151 44,174 39,340 Effect of potentially dilutive share-based awards — — — Diluted weighted average shares outstanding 47,151 44,174 39,340 Unvested participating shares excluded from basic weighted average shares outstanding since the securityholders are not obligated to fund losses 20 72 312 Common share equivalents excluded from the diluted weighted average shares outstanding since Veeco incurred a net loss and their effect would be antidilutive 28 239 107 Potentially dilutive non-participating shares excluded from the diluted calculation as their effect would be antidilutive 2,474 1,744 1,896 Maximum potential shares to be issued for settlement of the Convertible Senior Notes excluded from the diluted calculation as their effect would be antidilutive 8,618 8,618 — |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Dec. 31, 2018 | |
Fair Value Measurements | |
Fair Value Measurements | Note 3 — Fair Value Measurements Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. The Company is required to classify certain assets and liabilities based on the following fair value hierarchy: · Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities; · Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and · Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The Company has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions or estimation methodologies could have a significant effect on the estimated fair value amounts. The following table presents the Company’s assets that were measured at fair value on a recurring basis at December 31, 2018 and 2017: Level 1 Level 2 Level 3 Total (in thousands) December 31, 2018 Cash equivalents Certificate of deposits and time deposits $ 65,571 $ — $ — $ 65,571 U.S. treasuries 3,990 — — 3,990 Total $ 69,561 $ — $ — $ 69,561 Short-term investments U.S. treasuries $ 37,184 $ — $ — $ 37,184 Corporate debt — 8,516 — 8,516 Commercial paper — 2,489 — 2,489 Total $ 37,184 $ 11,005 $ — $ 48,189 December 31, 2017 Cash equivalents Certificate of deposits and time deposits $ 64,249 $ — $ — $ 64,249 U.S. treasuries 12,490 — — 12,490 Total $ 76,739 $ — $ — $ 76,739 Short-term investments U.S. treasuries $ 33,895 $ — $ — $ 33,895 Corporate debt — 10,886 — 10,886 Commercial paper — 2,999 — 2,999 Total $ 33,895 $ 13,885 $ — $ 47,780 The Company’s investments classified as Level 1 are based on quoted prices that are available in active markets. The Company’s investments classified as Level 2 are valued using observable inputs to quoted market prices, benchmark yields, reported trades, broker/dealer quotes, or alternative pricing sources with reasonable levels of price transparency. |
Investments
Investments | 12 Months Ended |
Dec. 31, 2018 | |
Investments | |
Investments | Note 4 — Investments At December 31, 2018 and 2017 the amortized cost and fair value of marketable securities were as follows: Gross Gross Amortized Unrealized Unrealized Estimated Cost Gains Losses Fair Value (in thousands) December 31, 2018 U.S. treasuries $ 37,191 $ — $ (7) $ 37,184 Corporate debt 8,525 — (9) 8,516 Commercial paper 2,489 — — 2,489 Total $ 48,205 $ — $ (16) $ 48,189 December 31, 2017 U.S. treasuries $ 33,914 $ — $ (19) $ 33,895 Corporate debt 10,894 — (8) 10,886 Commercial paper 2,999 — — 2,999 Total $ 47,807 $ — $ (27) $ 47,780 Available-for-sale securities in a loss position at December 31, 2018 and 2017 were as follows: December 31, 2018 December 31, 2017 Gross Gross Estimated Unrealized Estimated Unrealized Fair Value Losses Fair Value Losses (in thousands) U.S. treasuries $ 37,184 $ (7) $ 33,895 $ (19) Corporate debt 8,516 (9) 10,886 (8) Total $ 45,700 $ (16) $ 44,781 $ (27) At December 31, 2018 and 2017, there were no short-term investments that had been in a continuous loss position for more than 12 months. The maturities of securities classified as available-for-sale at December 31, 2018 were all due in one year or less. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. The realized gains or losses for the years ended December 31, 2018, 2017, and 2016 were immaterial. Other Investments Veeco has an ownership interest of less than 20% in a non-marketable investment, Kateeva, Inc. (“Kateeva”), over which Veeco does not exert significant influence. The carrying value of the investment was $21.0 million at December 31, 2018 and 2017. Additionally, during the year ended December 31, 2018, the Company made a separate non-marketable investment of $3.5 million in another entity. The Company does not exert significant influence over this investment and its ownership interest is less than 20%. Neither equity investment has a readily observable market price, and therefore the Company has elected to measure these investments at cost, adjusted for changes in observable market prices minus impairment. The investments are included in “Other assets” on the Consolidated Balance Sheets. There were no changes in observable market prices for either investment for the year ended December 31, 2018. These investments are subject to periodic impairment reviews; as there are no open-market valuations, the impairment analyses require judgment. The analyses include assessments of the companies’ financial condition, the business outlooks for their products and technologies, their projected results and cash flow, business valuation indications from recent rounds of financing, the likelihood of obtaining subsequent rounds of financing, and the impact of equity preferences held by Veeco relative to other investors. There were no impairment charges recorded for either investment for the years ended December 31, 2018, 2017, or 2016. |
Business Combinations
Business Combinations | 12 Months Ended |
Dec. 31, 2018 | |
Business Combinations | |
Business Combinations | Note 5 — Business Combinations Ultratech On May 26, 2017, the Company completed its acquisition of Ultratech, Inc. (“Ultratech”). Ultratech develops, manufactures, sells, and supports lithography, laser annealing, and inspection equipment for manufacturers of semiconductor devices, including front-end semiconductor manufacturing and advanced packaging. Ultratech also develops, manufactures, sells, and supports ALD equipment for scientific and industrial applications. Ultratech’s customers are primarily located throughout the United States, Europe, China, Japan, Taiwan, Singapore, and Korea. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition. Ultratech shareholders received (i) $21.75 per share in cash and (ii) 0.2675 of a share of Veeco common stock for each Ultratech common share outstanding on the acquisition date. The acquisition date fair value of the consideration totaled $633.4 million, net of cash acquired, which consisted of the following: Acquisition Date (May 26, 2017) (in thousands) Cash consideration, net of cash acquired of $229.4 million $ 404,490 Equity consideration (7.2 million shares issued) 228,643 Replacement equity awards attributable to pre-acquisition service 228 Acquisition date fair value $ 633,361 Approximately $2.7 million of the cash merger consideration is included in “Accrued expenses and other current liabilities” on the Consolidated Balance Sheets as of December 31, 2017 related to shareholder appraisal proceedings that were subsequently settled and paid during 2018. The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date: Acquisition Date (May 26, 2017) (in thousands) Short-term investments $ 47,161 Accounts receivable 45,465 Inventories 59,100 Deferred cost of sales 242 Prepaid expense and other current assets 7,217 Property, plant, and equipment 18,152 Intangible assets 346,940 Other assets 6,442 Total identifiable assets acquired 530,719 Accounts payable 24,291 Accrued expenses and other current liabilities 16,356 Customer deposits and deferred revenue 4,834 Deferred income taxes 32,478 Other liabilities 11,622 Total liabilities assumed 89,581 Net identifiable assets acquired 441,138 Goodwill 192,223 Net assets acquired $ 633,361 The gross contractual value of the acquired accounts receivable was approximately $46.0 million. The fair value of the accounts receivables is the amount expected to be collected by the Company. Goodwill generated from the acquisition is primarily attributable to expected synergies from future growth and strategic advantages provided through the expansion of product offerings as well as assembled workforce and is not expected to be deductible for income tax purposes. The classes of intangible assets acquired and the estimated useful life of each class is presented in the table below: Acquisition Date (May 26, 2017) Amount Useful life (in thousands) Technology $ 158,390 9 years Customer relationships 116,710 12 years Backlog 3,080 6 months In-process research and development 43,340 * Trademark and tradenames 25,420 7 years Intangible assets acquired $ 346,940 * In-process research and development will be amortized (or impaired) upon completion (or abandonment) of the development project. The Company determined the estimated fair value of the identifiable intangible assets based on various factors including: cost, discounted cash flow, income method, loss-of-revenue/income method, and relief-from-royalty method in determining the purchase price allocation. In-process research and development (“IPR&D”) represents the estimated fair values of incomplete Ultratech research and development projects that had not reached the commercialization stage and met the criteria for recognition as IPR&D as of the date of the acquisition. The fair value of IPR&D was determined using an income approach and costs to complete the project and expected commercialization timelines are considered key assumptions. This valuation approach reflected the present value of the projected cash flows that were expected to be generated by the IPR&D less charges representing the contribution of other assets to those cash flows. The value of the IPR&D was determined to be $43.3 million, approximately half of which was related to Ultratech’s lithography technologies and one-third of which was related to Ultratech’s laser annealing technologies. During the second quarter of 2018, the Company lowered its projected results for the Ultratech asset group and determined that the revised projections were significantly lower than projected results at the time of the acquisition and that these revised projections required the Company to assess the Ultratech asset group for impairment. See Note 6, “Goodwill and Intangible Assets,” for additional information. For the year ended December 31, 2018 and 2017, acquisition related costs were approximately $3.0 million and $17.8 million, respectively, including non-cash charges of $4.2 million related to accelerated share-based compensation for employee terminations for the year ended December 31, 2017. The amounts of net sales and income (loss) from operations before income taxes of Ultratech included in the Company’s Consolidated Statement of Operations for the year ended December 31, 2017 are as follows: Year ended December 31, 2017 (in thousands) Net sales $ 65,280 Loss before income taxes $ (62,284) Loss before income taxes of Ultratech for the year ended December 31, 2017 of $62.3 million includes acquisition costs of $17.8 million, release of inventory fair value step-up related to purchase accounting of $9.6 million, amortization expense on intangible assets of $23.9 million, and restructuring charges of $3.3 million. The following table presents unaudited pro forma financial information as if the acquisition of Ultratech had occurred on January 1, 2016: For the year ended December 31, 2017 2016 (in thousands, except per share amounts) Net sales $ 546,428 $ 525,752 Loss before income taxes (90,000) (217,783) Diluted earnings per share $ (1.38) $ (4.67) The pro-forma results were calculated by combining the audited results of the Company with the stand-alone unaudited results of Ultratech for the pre-acquisition period, and adjusting for the following: (i) Additional amortization expense related to identified intangible assets valued as part of the purchase price allocation that would have been incurred starting on January 1, 2016. (ii) Additional depreciation expense for the property, plant, and equipment fair value adjustments that would have been incurred starting on January 1, 2016. (iii) All acquisition related costs incurred by the Company as well as by Ultratech pre-acquisition have been removed from the year ended December 31, 2017 and included in the year ended December 31, 2016, as such expenses would have been incurred in the first quarter following the acquisition. (iv) All amortization of inventory step-up has been removed from the year ended December 31, 2017 and recorded in the year ended December 31, 2016, as such costs would have been incurred as the corresponding inventory was sold. (v) Additional interest expense related to the Convertible Senior Notes (see Note 12, “Debt”) as if they had been issued on January 1, 2016. (vi) Income tax expense (benefit) was adjusted for the impact of the above adjustments for each period. (vii) All shares issued in connection with the acquisition were considered outstanding as of January 1, 2016 for purposes of calculating diluted earnings per share. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 12 Months Ended |
Dec. 31, 2018 | |
Goodwill and Intangible Assets | |
Goodwill and Intangible Assets | Note 6 — Goodwill and Intangible Assets Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The following table presents the changes in goodwill balances during the years indicated: Gross carrying Accumulated amount impairment Net amount (in thousands) Balance at December 31, 2016 $ 238,108 $ 123,200 $ 114,908 Acquisition 192,223 — 192,223 Balance at December 31, 2017 430,331 123,200 307,131 Impairment — 122,829 (122,829) Balance at December 31, 2018 $ 430,331 $ 246,029 $ 184,302 The Company performs its annual goodwill impairment test at the beginning of the fourth quarter each year. As the Company maintains a single goodwill reporting unit, it determines the fair value of its reporting unit based upon the Company’s adjusted market capitalization. The adjusted market capitalization is calculated by multiplying the average share price of the Company’s common stock for the last ten trading days prior to the measurement date by the number of outstanding common shares and adding a control premium. The control premium is estimated using historical transactions in similar industries. The annual test performed at the beginning of the fourth quarter of fiscal 2017 and 2018 did not result in any potential impairment as the fair value of the reporting unit was determined to exceed the carrying amount of the reporting unit. As a result of a significant decline in the Company’s stock price during the fourth quarter, the Company concluded it was appropriate to perform an interim goodwill impairment test as of the end of the fourth quarter. The fair value of its reporting unit, as calculated using the adjusted market capitalization approach noted above, was determined to be below the carrying value of the reporting unit, and the Company recorded an impairment charge equal to the excess of carrying value over fair value, or $122.8 million, for the year ended December 31, 2018. The impairment charge is included in “Asset impairment” in the Consolidated Statements of Operations. The valuation of goodwill will continue to be subject to changes in the Company’s market capitalization and observable market control premiums. This analysis is sensitive to changes in the Company’s stock price and absent other qualitative factors, the Company may be required to record additional goodwill impairment charges in future periods if the stock price declines and remains depressed for an extended period of time. The components of purchased intangible assets were as follows: December 31, 2018 December 31, 2017 Weighted Average Accumulated Accumulated Remaining Gross Amortization Gross Amortization Amortization Carrying and Net Carrying and Net Period Amount Impairment Amount Amount Impairment Amount (in years) (in thousands) Technology 6.4 $ 337,218 $ 290,808 $ 46,410 $ 307,588 $ 133,121 $ 174,467 Customer relationships 10.2 164,595 136,126 28,469 164,595 39,336 125,259 In-process R&D — 13,710 10,530 3,180 43,340 — 43,340 Trademarks and tradenames 5.4 30,910 23,899 7,011 30,910 4,321 26,589 Other 1.3 3,686 3,607 79 3,686 3,498 188 Total 7.3 $ 550,119 $ 464,970 $ 85,149 $ 550,119 $ 180,276 $ 369,843 Other intangible assets primarily consist of patents, licenses, and backlog. During the second quarter of 2018, the Company lowered its projected results for the Ultratech asset group, which were significantly below the projected results at the time of the acquisition. The reduced projections were based on lower than expected unit volume of certain smartphones, which incorporate advanced packaging methods such as fan-out wafer level packaging (“FOWLP”), and a delay in the adoption of FOWLP advanced packaging by other electronics manufacturers, both of which slowed orders and reduced revenue projections for the Company’s advanced packaging lithography systems. In addition, there has been a delay in the build out of 28nm facilities by companies in China who were expected to purchase the Company’s Laser Spike Anneal systems. Taken together, the reduced projections identified during the second quarter of 2018 required the Company to assess the Ultratech asset group for impairment. As a result of the analysis, which included projected cash flows that required the use of unobservable inputs, the Company recorded non-cash impairment charges of $216.4 million and $35.9 million related to definite-lived intangible assets and in-process research and development assets, respectively, during the second quarter of 2018. The impairment charge is included in “Asset impairment” in the Consolidated Statement of Operations. Subsequently, certain in-process research and development projects were completed and moved to the “Technology” line in the above table. During 2016, the Company decided to reduce future investments in certain technologies and, as a result, recorded a non-cash impairment charge of $54.3 million for the related intangible purchased technology. The impairment charge was based on projected cash flows that required the use of unobservable inputs and was recorded in “Asset impairment” in the Consolidated Statements of Operations. Based on the intangible assets recorded at December 31, 2018, and assuming no subsequent additions to or impairment of the underlying assets, the remaining estimated annual amortization expense, excluding in-process R&D, is expected to be as follows: Amortization (in thousands) 2019 $ 16,820 2020 15,894 2021 12,772 2022 10,438 2023 8,675 Thereafter 17,370 Total $ 81,969 |
Inventories
Inventories | 12 Months Ended |
Dec. 31, 2018 | |
Inventories | |
Inventories | Note 7 — Inventories Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventories consist of the following: December 31, 2018 2017 (in thousands) Materials $ 90,816 $ 59,919 Work-in-process 42,354 37,222 Finished goods 23,141 23,125 Total $ 156,311 $ 120,266 |
Property, Plant, and Equipment
Property, Plant, and Equipment and Assets Held for Sale | 12 Months Ended |
Dec. 31, 2018 | |
Property, Plant, and Equipment and Assets Held for Sale | |
Property, Plant, and Equipment and Assets Held for Sale | Note 8 — Property, Plant, and Equipment and Assets Held for Sale Property and equipment, net, consist of the following: December 31, 2018 2017 Average Useful Life (in thousands) Land $ 5,669 $ 5,669 N/A Building and improvements 61,124 54,449 10 – 40 years Machinery and equipment (1) 128,385 126,829 3 – 10 years Leasehold improvements 9,033 10,073 3 – 7 years Gross property, plant, and equipment 204,211 197,020 Less: accumulated depreciation and amortization 123,927 111,962 Net property, plant, and equipment $ 80,284 $ 85,058 (1) Machinery and equipment also includes software, furniture, and fixtures Depreciation expense was $17.6 million, $14.6 million, and $13.4 million for the years ended December 31, 2018, 2017, and 2016, respectively. During 2016, the Company decided to reduce future investments in certain technologies and, as a result, recorded an impairment charge of $3.3 million of property, plant, and equipment. As part of the Company’s efforts to reduce costs, enhance efficiency, and streamline operations, the Company removed certain lab equipment that is no longer required and recorded a non-cash impairment charge of $6.2 million for the year ended December 31, 2016. Additionally, as part of that initiative, the Company listed its two facilities in South Korea for sale. When each facility was reclassified as held for sale, the Company determined that the carrying values of the buildings exceeded their fair market values, less cost to sell, and recorded net impairment charges of $4.5 million for the year ended December 31, 2016. Both facilities were sold before the end of 2016 at prices that approximated the revised carrying values. Finally, during the year ended December 31, 2016, the Company recorded an impairment charge of approximately $1.2 million related to an owned property in St. Paul, Minnesota. The property was sold during 2017, resulting in an additional impairment charge of $0.7 million for the year ended December 31, 2017. There were no assets held for sale as of December 31, 2018 and 2017. All impairment charges were recorded in “Asset impairment” in the Consolidated Statements of Operations. |
Accrued Expenses and Other Liab
Accrued Expenses and Other Liabilities | 12 Months Ended |
Dec. 31, 2018 | |
Accrued Expenses and Other Liabilities | |
Accrued Expenses and Other Liabilities | Note 9 — Accrued Expenses and Other Liabilities The components of accrued expenses and other current liabilities were as follows: December 31, 2018 2017 (in thousands) Payroll and related benefits $ 20,486 $ 32,996 Warranty 7,852 6,532 Interest 4,321 4,430 Professional fees 2,897 3,942 Merger consideration payable — 2,662 Sales, use, and other taxes 2,670 2,144 Restructuring liability 2,213 1,520 Other 6,011 3,842 Total $ 46,450 $ 58,068 Customer deposits and deferred revenue Customer deposits totaled $28.3 million and $41.5 million at December 31, 2018 and 2017, respectively, which are included in “Customer deposits and deferred revenue” in the Consolidated Balance Sheets. Deferred revenue represents amounts billed, other than deposits, in excess of the revenue that can be recognized on a particular contract at the balance sheet date. Changes in deferred revenue were as follows: (in thousands) Balance - December 31, 2017 $ 70,536 Deferral of revenue 10,251 Recognition of previously deferred revenue (36,372) Balance - December 31, 2018 $ 44,415 As of December 31, 2018, the Company has approximately $74.0 million of remaining performance obligations on contracts with an original estimated duration of one year or more, of which approximately 67% is expected to be recognized within one year, with the remaining amounts expected to be recognized between one to three years. The Company has elected to exclude disclosures regarding remaining performance obligations that have an original expected duration of one year or less. Other liabilities As part of the acquisition of Ultratech, the Company assumed an executive non-qualified deferred compensation plan that allowed qualifying executives to defer cash compensation. The plan was frozen at the time of acquisition and no further contributions have been made. At December 31, 2018 and 2017, plan assets approximated $3.2 million and $3.4 million, respectively, representing the cash surrender value of life insurance policies and is included within “Other assets” in the Consolidated Balance Sheets, while plan liabilities approximated $3.5 million and $4.7 million, respectively and is included within “Other liabilities” in the Consolidated Balance Sheets. Other liabilities also included asset retirement obligations of $3.2 million and $3.3 million at December 31, 2018 and 2017, respectively, medical and dental benefits for former executives of $2.2 million at both December 31, 2018 and 2017, and income tax payables of $1.0 million at December 31, 2018. |
Restructuring Charges
Restructuring Charges | 12 Months Ended |
Dec. 31, 2018 | |
Restructuring Charges | |
Restructuring Charges | Note 10 — Restructuring Charges During 2017, the Company initiated certain restructuring activities related to the Company’s efforts to streamline operations, enhance efficiencies, and reduce costs, as well as reduce the Company’s investments in certain technology development. In addition, during 2017, the Company began the Ultratech acquisition integration process to enhance efficiencies, resulting in reductions in headcount and other facility costs. During the year ended December 31, 2018, additional accruals were recognized and payments were made related to these restructuring initiatives. During the second quarter of 2018, the Company initiated plans to further reduce excess capacity associated with the manufacture and support of the Company’s advanced packaging lithography and 3D wafer inspection systems by consolidating these operations into its San Jose, California facility. As a result of this and other cost saving initiatives, the Company announced headcount reductions of approximately 40 employees and recorded restructuring charges related to these actions of $2.8 million for the year ended December 31, 2018, consisting principally of personnel severance and related costs. The Company expects the consolidation to be completed in the first quarter of 2019, and expects to incur immaterial additional restructuring costs as this initiative is completed. During the third quarter of 2018, the Company initiated additional restructuring activities to further reduce costs, including headcount reductions impacting approximately 35 employees and recorded restructuring charges related to these actions of $1.2 million, consisting principally of personnel severance and related costs. This initiative was completed by the end of 2018. Restructuring expense for the year ended December 31, 2018 included non-cash charges of $1.2 million related to accelerated share-based compensation for employee terminations, compared to $1.9 million for the comparable prior year period. The following table shows the amounts incurred and paid for restructuring activities during the years ended December 31, 2018, 2017, and 2016 and the remaining accrued balance of restructuring costs at December 31, 2018, which is included in “Accrued expenses and other current liabilities” in the Consolidated Balance Sheets: Personnel Facility Severance and Related Costs Related Costs and Other Total (in thousands) Balance - December 31, 2015 $ 824 $ — $ 824 Provision 4,544 1,098 5,642 Changes in estimate (2) — (2) Payments (3,570) (1,098) (4,668) Balance - December 31, 2016 1,796 — 1,796 Provision 4,714 5,257 9,971 Payments (4,990) (5,257) (10,247) Balance - December 31, 2017 1,520 — 1,520 Provision 4,681 2,714 7,395 Payments (4,058) (2,644) (6,702) Balance - December 31, 2018 $ 2,143 $ 70 $ 2,213 |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2018 | |
Commitments and Contingencies | |
Commitments and Contingencies | Note 11 — Commitments and Contingencies Warranty The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance by providing labor and parts necessary to repair the systems during the warranty period. The Company accounts for the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of sales” in the Consolidated Statements of Operations. The estimated warranty cost is based on the Company’s historical experience with its systems and regional labor costs. The Company calculates the average service hours by region and parts expense per system utilizing actual service records to determine the estimated warranty charge. The Company updates its warranty estimates on a quarterly basis when the actual product performance or field expense differs from original estimates. Changes in the Company’s product warranty reserves were as follows: December 31, 2018 2017 2016 (in thousands) Balance, beginning of the year $ 6,532 $ 4,217 $ 8,159 Warranties issued 6,737 5,817 3,916 Addition from Ultratech acquisition — 1,889 — Consumption of reserves (6,573) (6,330) (6,433) Changes in estimate 1,156 939 (1,425) Balance, end of the year $ 7,852 $ 6,532 $ 4,217 Minimum Lease Commitments Minimum lease commitments at December 31, 2018 for property and equipment under operating lease agreements (exclusive of renewal options) are payable as follows: Operating Leases (in thousands) Payments due by period: 2019 $ 5,143 2020 5,056 2021 2,432 2022 1,812 2023 1,066 Thereafter 548 Total $ 16,057 Lease expense was $6.3 million, $5.3 million, and $2.5 million for the years ended December 31, 2018, 2017, and 2016, respectively. In addition, the Company is obligated under such leases for certain other expenses, including real estate taxes and insurance. Legal Proceedings On June 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech acquisition (the “Wolther Action”). On August 2 and August 8, 2018, two purported class action complaints substantially similar to the Wolther Action were filed on behalf of different plaintiffs in the same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the Securities Act of 1933 for, among other things, alleged false/misleading statements in the registration statement and prospectus relating to the Ultratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased MOCVD competition in China, and an intellectual property dispute. The defendants filed a demurrer on January 10, 2019, asking the court to dismiss the consolidated complaint for failure to state a claim. The demurrer is scheduled to be heard by the court on March 15, 2019. Veeco believes this lawsuit is without merit and intends to vigorously contest this matter. On December 21, 2018, a purported Veeco stockholder filed a derivative action in the Superior Court of the State of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco. The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the registration statement relating to the Ultratech acquisition. On January 2, 2019, the court ordered this action stayed until the case management conference, which is scheduled for March 15, 2019. Veeco believes this lawsuit is without merit and intends to vigorously contest this matter. The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows. Concentrations of Credit Risk The Company depends on purchases from its ten largest customers, which accounted for 61% and 67% of net accounts receivable at December 31, 2018 and 2017, respectively. Customers who accounted for more than 10% of net accounts receivable or net sales are as follows: Accounts Receivable Net Sales December 31, For the Year Ended December 31, Customer 2018 2017 2018 2017 2016 Customer A * 24 % * 21 % 14 % Customer B 22 % * * * * Customer C * * 12 % * * * Less than 10% of aggregate accounts receivable or net sales The Company manufactures and sells its products to companies in different geographic locations. Refer to Note 18, “Segment Reporting and Geographic Information,” for additional information. In certain instances, the Company requires deposits from its customers for a portion of the sales price in advance of shipment and performs periodic credit evaluations on its customers. Where appropriate, the Company requires letters of credit on certain non-U.S. sales arrangements. Receivables generally are due within 30 to 90 days from the date of invoice. Receivable Purchase Agreement In December 2017, the Company entered into a Receivable Purchase Agreement with a financial institution to sell certain of its trade receivables from customers without recourse, up to $23.0 million at any point in time for a term of one year. Pursuant to this agreement, the Company sold $15.0 million of Receivables during the year ended December 31, 2017 and maintained $8.0 million available under the agreement for additional sales of Receivables as of December 31, 2017. No sales were made under this agreement in 2018, and the agreement was terminated in 2018. The net sale of accounts receivable, under the agreement is reflected as a reduction of accounts receivable in the Company’s Consolidated Balance Sheet at the time of sale and any fees for the sale of trade receivables were not material for the periods presented. Suppliers The Company outsources certain functions to third parties, including the manufacture of several of its systems. While the Company relies on its outsourcing partners to perform their contracted functions, the Company maintains some level of internal manufacturing capability for these systems. In addition, certain of the components and sub-assemblies included in the Company’s products are obtained from a single source or a limited group of suppliers. The failure of the Company’s present outsourcing partners and suppliers to meet their contractual obligations and the Company’s inability to make alternative arrangements or resume the manufacture of these systems could have a material adverse effect on the Company’s revenues, profitability, cash flows, and relationships with its customers. The Company had deposits with its suppliers of $12.8 million and $7.6 million at December 31, 2018 and 2017, respectively, that were included in “Prepaid expenses and other current assets” on the Consolidated Balance Sheets. Purchase Commitments The Company had purchase commitments of $91.5 million at December 31, 2018, substantially all of which will come due within one year. Purchase commitments are primarily for inventory used in manufacturing products and are partially offset by existing deposits with suppliers. Bank Guarantees The Company has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At December 31, 2018, outstanding bank guarantees and letters of credit totaled $6.8 million and unused bank guarantees and letters of credit of $58.9 million were available to be drawn upon. Other On November 1, 2018, the Company announced an attack on its computer systems. Upon learning of the attack, forensic experts were promptly engaged to assist with the investigation. The Company also notified law enforcement of the incident. The investigation, which has largely been completed, determined that the Company’s computer systems were accessed by what appears to be a highly-sophisticated actor at various times over a period of years. It appears that proprietary and confidential information of the Company and certain personal information of the Company’s employees was accessed and may have been compromised as a result of the incident. Based on the evidence available at this time, the extent and impact of the compromise cannot be determined. The Company notified employees of this incident. The Company is continuing to analyze the incident, along with appropriate remediation of the Company’s computer systems. That analysis and the related remediation efforts could ultimately reveal that additional information was revealed or compromised. Based on the evidence available at this time, the Company does not know if or when it will be able to determine the potential impact to the Company, whether it will be able to identify who is responsible for this attack or whether it will be able to pursue legal action or other remedies to protect any compromised information or recover damages related to the attack. This attack, including the expenses incurred to address it, may have an adverse effect on the Company’s results of operations and/or financial condition. In addition, this attack may have caused the loss or misuse of proprietary and confidential information of the Company or others, result in litigation and potential liability, damage the Company’s reputation and/or otherwise harm its business. |
Debt
Debt | 12 Months Ended |
Dec. 31, 2018 | |
Debt | |
Debt | Note 12 — Debt Convertible Senior Notes On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes (the “Convertible Senior Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The Convertible Senior Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The Convertible Senior Notes mature on January 15, 2023 (the “Maturity Date”), unless earlier purchased by the Company, redeemed, or converted. The Convertible Senior Notes are unsecured obligations of Veeco and rank senior in right of payment to any of Veeco’s subordinated indebtedness; equal in right of payment to all of Veeco’s unsecured indebtedness that is not subordinated; effectively subordinated in right of payment to any of Veeco’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’s subsidiaries. The Convertible Senior Notes are convertible into cash, shares of the Company’s common stock, or a combination thereof, at the Company’s election, upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rate is 24.9800 shares of the Company’s common stock per $1,000 principal amount of Convertible Senior Notes, representing an initial effective conversion price of $40.03 per share of common stock. The conversion rate may be subject to adjustment upon the occurrence of certain specified events as provided in the indenture governing the Convertible Senior Notes, dated January 18, 2017 between the Company and U.S. Bank National Association, as trustee, but will not be adjusted for accrued but unpaid interest. Holders may convert all or any portion of their notes, in multiples of one thousand dollar principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 2022 only under the following circumstances: (i) During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day; (iii) If the Company calls any or all of the Convertible Senior Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (iv) Upon the occurrence of specified corporate events. On or after October 15, 2022, until the close of business on the business day immediately preceding the Maturity Date, holders may convert their notes at any time, regardless of the foregoing circumstances. Upon conversion by the holders, the Company may elect to settle such conversion in shares of its common stock, cash, or a combination thereof. As a result of its cash conversion option, the Company segregated the liability component of the instrument from the equity component. The liability component was measured by estimating the fair value of a non-convertible debt instrument that is similar in its terms to the Convertible Senior Notes. The calculation of the fair value of the debt component required the use of Level 3 inputs, including utilization of convertible investors’ credit assumptions and high yield bond indices. Fair value was estimated through discounting future interest and principal payments, an income approach, due under the Convertible Senior Notes at a discount rate of 7.00%, an interest rate equal to the estimated borrowing rate for similar non-convertible debt. The excess of the aggregate face value of the Convertible Senior Notes over the estimated fair value of the liability component of $72.5 million was recognized as a debt discount and recorded as an increase to additional paid-in capital and will be amortized over the expected life of the Convertible Senior Notes using the effective interest rate method. Amortization of the debt discount is recognized as non-cash interest expense. The transaction costs of $9.2 million incurred in connection with the issuance of the Convertible Senior Notes were allocated to the liability and equity components based on their relative values. Transaction costs allocated to the liability component are being amortized using the effective interest rate method and recognized as non-cash interest expense over the expected term of the Convertible Senior Notes. Transaction costs allocated to the equity component of $1.9 million reduced the value of the equity component recognized in stockholders' equity. The carrying value of the Convertible Senior Notes is as follows: December 31, 2018 2017 (in thousands) Principal amount $ 345,000 $ 345,000 Unamortized debt discount (52,336) (63,022) Unamortized transaction costs (5,272) (6,348) Net carrying value $ 287,392 $ 275,630 Total interest expense related to the Convertible Senior Notes is as follows: For the year ended December 31, 2018 2017 (in thousands) Cash Interest Expense Coupon interest expense $ 9,315 $ 8,901 Non-Cash Interest Expense Amortization of debt discount 10,686 9,490 Amortization of transaction costs 1,076 956 Total Interest Expense $ 21,077 $ 19,347 The Company determined the Convertible Senior Notes is a Level 2 liability in the fair value hierarchy and estimated its fair value as $255.3 million at December 31, 2018. |
Derivative Financial Instrument
Derivative Financial Instruments | 12 Months Ended |
Dec. 31, 2018 | |
Derivative Financial Instruments | |
Derivative Financial Instruments | Note 13 — Derivative Financial Instruments The Company is exposed to financial market risks arising from changes in currency exchange rates. Changes in currency exchange rate changes could affect the Company’s foreign currency denominated monetary assets and liabilities and forecasted cash flows. The Company entered into monthly forward derivative contracts with the intent of mitigating a portion of this risk. The Company only used derivative financial instruments in the context of hedging and not for speculative purposes and had not designated its foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts were recorded as “Other, net” in the Company’s Consolidated Statements of Operations. The Company executed derivative transactions with highly rated financial institutions to mitigate counterparty risk. The Company did not have any outstanding derivative contracts at December 31, 2018. A summary of the foreign exchange derivatives outstanding on December 31, 2017 is as follows: December 31, 2017 Fair Value Maturity Dates Notional Amount (in thousands) Foreign currency exchange forwards $ — January 2018 $ 622 The following table shows the gains and (losses) from currency exchange derivatives during the years ended December 31, 2018, 2017, and 2016, which are included in “Other, net” in the Consolidated Statements of Operations as well as the weighted average notional amount of derivatives outstanding for each period: Year ended December 31, 2018 2017 2016 Gains (losses) Weighted average notional amount Gains (losses) Weighted average notional amount Gains (losses) Weighted average notional amount (in thousands) Foreign currency exchange forwards $ 327 2,869 $ (6) 314 $ 219 7,175 |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Dec. 31, 2018 | |
Equity | |
Equity | Note 14 — Stockholders’ Equity Accumulated Other Comprehensive Income The following table presents the changes in the balances of each component of AOCI, net of tax: Unrealized Gains (Losses) Foreign Minimum on Available Currency Pension for Sale Translation Liability Securities Total (in thousands) Balance - December 31, 2015 $ 2,246 $ (866) $ (32) $ 1,348 Other comprehensive income (loss), before reclassifications (19) — (6) (25) Amounts reclassified from AOCI (430) 866 18 454 Other comprehensive income (loss) (449) 866 12 429 Balance - December 31, 2016 1,797 — (20) 1,777 Other comprehensive income (loss) 42 — (7) 35 Balance - December 31, 2017 1,839 — (27) 1,812 Other comprehensive income (loss) (3) — 11 8 Balance - December 31, 2018 $ 1,836 $ — $ (16) $ 1,820 The Company did not allocate additional tax expense (benefit) to other comprehensive income (loss) for all years presented as the Company is in a full valuation allowance position such that a deferred tax asset related to amounts recognized in other comprehensive income is not regarded as realizable on a more-likely-than-not basis. During 2016, the Company finalized the process to terminate a defined benefit plan. As a result, the Company reclassified the minimum pension liability of $0.9 million, net of a tax benefit of $0.4 million, from “Accumulated other comprehensive income” in the Consolidated Balance Sheets to “Other, net” in the Consolidated Statements of Operations. Additionally, the Company completed its plan to liquidate one of its subsidiaries in Korea. As a result of this liquidation, a cumulative translation gain of $0.4 million was reclassified from “Accumulated other comprehensive income” to “Other, net” in the Consolidated Statements of Operations. Preferred Stock The Board of Directors has authority under the Company’s Certificate of Incorporation to issue shares of preferred stock, par value $0.01, with voting and economic rights to be determined by the Board of Directors. As of December 31, 2018, no preferred shares have been issued. Treasury Stock The share repurchase program authorized by the Company’s Board of Directors in October 2015 expired on October 28, 2017. On December 11, 2017, the Company’s Board of Directors authorized a new program to repurchase up to $100 million of the Company’s common stock to be completed through December 11, 2019. The Company records treasury stock purchases under the cost method using the first-in, first-out (“FIFO”) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If the Company reissues treasury stock at an amount below its acquisition cost and if additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between the acquisition cost and the reissue price, this difference is charged to accumulated deficit. |
Stock Plans
Stock Plans | 12 Months Ended |
Dec. 31, 2018 | |
Stock Plans | |
Stock Plans | Note 15 — Stock Plans Share-based incentive awards are provided to employees under the terms of the Company’s equity incentive compensation plans (the “Plans”), which are administered by the Compensation Committee of the Board of Directors. The 2010 Plan was approved by the Company’s shareholders. The Company’s employees, non-employee directors, and consultants are eligible to receive awards under the 2010 Stock Incentive Plan (as amended to date, the “2010 Plan”), which can include non-qualified stock options, incentive stock options, restricted share awards (“RSAs”), restricted share units (“RSUs”), performance share awards (“PSAs”), performance share units (“PSUs”), share appreciation rights, dividend equivalent rights, or any combination thereof. The Company settles awards under the Plans with newly issued shares or with shares held in treasury. In 2013, the Board of Directors granted equity awards to certain employees under the Company’s 2013 Inducement Stock Incentive Plan (the “Inducement Plan”). The Company issued 124,500 stock option shares and 87,000 RSUs under this plan. Stock options under this plan vest over a three year period and have a 10-year term, and RSUs under this plan vest over a two or four year period. At December 31, 2013, the Inducement Plan was merged into the 2010 Plan and is considered an inactive plan with no further shares available for grant. At December 31, 2018, there are 2,000 option shares and no RSUs outstanding under the Inducement Plan. The Company is authorized to issue up to 10.6 million shares under the 2010 Plan, including additional shares authorized under plan amendments approved by shareholders in 2016 and 2013. Option awards are granted with an exercise price equal to the closing price of the Company’s common stock on the trading day prior to the date of grant; option awards generally vest over a three year period and have a seven or ten year term. RSAs and RSUs generally vest over one to five years. Certain option and share awards provide for accelerated vesting if there is a change in control, as defined in the 2010 Plan. At December 31, 2018, there are 1.2 million option shares and 0.9 million RSUs and PSUs outstanding under the 2010 Plan. During 2016, the Company’s Board of Directors approved the 2016 Employee Stock Purchase Plan (“ESPP”). The Company is authorized to issue up to 750,000 shares under the ESPP. Under the ESPP, substantially all employees in the U.S. may purchase the Company’s common stock through payroll deductions at a price equal to 85 percent of the lower of the fair market value of the Company’s common stock at the beginning or end of each six-month Offer Period, as defined in the ESPP, and subject to certain limits. The ESPP was approved by the Company’s shareholders. During 2017, in connection with the acquisition of Ultratech, the Company assumed certain restricted stock units (the “Assumed RSUs”) available and outstanding under the Ultratech, Inc. 1993 Stock Option/Stock Issuance Plan, as amended (the “Ultratech Plan”). The Assumed RSUs remain subject to the terms set forth in the award agreement governing the award and the Ultratech Plan, except that the Assumed RSUs relate to shares of Company common stock and the number of restricted stock units was adjusted pursuant to the terms of the acquisition to reflect the difference in the value of a share of Company common stock and a share of Ultratech common stock prior to closing the acquisition. The Assumed RSUs were converted into 338,144 restricted stock units of the Company and generally vest over 50 months. After the acquisition and notwithstanding any other provisions of the Ultratech Plan, no further grants will be made under the Ultratech Plan, and the Company is solely maintaining the Ultratech Plan with respect to the Assumed RSUs. At December 31, 2018, there are 30,200 RSUs outstanding under the Ultratech Plan. Shares Reserved for Future Issuance At December 31, 2018, the Company has 4.5 million shares reserved to cover exercises of outstanding stock options, vesting of RSUs, and additional grants under the 2010 Plan. At December 31, 2018, the Company has 0.2 million shares reserved to cover future issuances under the ESPP Plan. Share-Based Compensation The Company recognized share-based compensation in the following line items in the Consolidated Statements of Operations for the periods indicated: For the year ended December 31, 2018 2017 2016 (in thousands) Cost of sales $ 1,885 $ 2,505 $ 1,956 Research and development 3,611 2,957 3,324 Selling, general, and administrative 9,417 12,851 10,433 Restructuring 1,161 1,880 — Acquisition costs — 4,203 — Total $ 16,074 $ 24,396 $ 15,713 The Company did not realize any tax benefits associated with share-based compensation for the years ended December 31, 2018, 2017, and 2016 due to the full valuation allowance on its U.S. deferred tax assets. See Note 17, “Income Taxes” for additional information. The Company capitalized an immaterial amount of share-based compensation into inventory for the years ended December 31, 2018, 2017, and 2016. Unrecognized share-based compensation costs at December 31, 2018 are summarized below: Unrecognized Weighted Share-Based Average Period Compensation Expected to be Costs Recognized (in thousands) (in years) Stock option awards $ — — Restricted stock units 2,466 2.4 Restricted stock awards 19,663 2.6 Performance share units 7,356 2.4 Total unrecognized share-based compensation cost $ 29,485 2.5 Stock Option Awards Stock options are awards issued to employees that entitle the holder to purchase shares of the Company’s stock at a fixed price. At December 31, 2018, options outstanding that have vested and are expected to vest are as follows: Weighted Number Weighted Average Aggregate of Average Remaining Intrinsic Shares Exercise Price Contractual Life Value (in thousands) (in years) (in thousands) Vested 1,222 $ 34.80 3.0 — Expected to vest — — — — Total 1,222 34.80 3.0 — The aggregate intrinsic value represents the difference between the option exercise price and $7.41, the closing price of the Company’s common stock on December 31, 2018, the last trading day of the Company’s fiscal year as reported on the NASDAQ Stock Market. Additional information with respect to stock option activity: Weighted Number of Average Shares Exercise Price (in thousands) Balance - December 31, 2015 2,064 $ 32.91 Granted — — Exercised (194) 12.18 Expired or forfeited (294) 34.44 Balance - December 31, 2016 1,576 35.18 Granted — — Exercised (18) 30.03 Expired or forfeited (164) 37.47 Balance - December 31, 2017 1,394 34.97 Granted — — Exercised — — Expired or forfeited (172) 36.21 Balance - December 31, 2018 1,222 34.80 The following table summarizes stock option information at December 31, 2018: Options Outstanding Options Exercisable Weighted Weighted Aggregate Average Weighted Aggregate Average Weighted Intrinsic Remaining Average Intrinsic Remaining Average Range of Exercise Prices Shares Value Contractual Life Exercise Price Shares Value Contractual Life Exercise Price (in thousands) (in thousands) (in years) (in thousands) (in thousands) (in years) $20.00 - $30.00 25 $ — 3.6 $ 28.13 25 $ — 3.6 $ 28.13 $30.01 - $40.00 1,058 — 3.1 32.81 1,058 — 3.1 32.81 $40.01 - $50.00 12 — 1.7 45.57 12 — 1.7 45.57 $50.01 - $60.00 127 — 2.4 51.70 127 — 2.4 51.70 1,222 $ — 3.0 34.80 1,222 $ — 3.0 34.80 The following table summarizes information on options exercised for the periods indicated: Year ended December 31, 2018 2017 2016 (in thousands) Cash received from options exercised $ — $ 431 $ 494 Intrinsic value of options exercised $ — $ 51 $ 1,165 RSAs, RSUs, PSAs, PSUs RSAs are stock awards issued to employees that are subject to specified restrictions and a risk of forfeiture. RSUs are stock awards issued to employees that entitle the holder to receive shares of common stock as the awards vest. PSAs and PSUs are awards that result in an issuance of shares of common stock to employees if certain performance or market conditions are achieved. All of these awards typically vest over one to five years and vesting is subject to the employee's continued service with the Company and, in the case of performance awards, meeting certain performance or market conditions. The fair value of the awards is determined and fixed based on the closing price of the Company’s common stock on the trading day prior to the date of grant, or, in the case of performance awards with market conditions, fair value is determined using a Monte Carlo simulation. The following table summarizes the equity activity of non-vested restricted shares and performance shares: Weighted Average Number of Grant Date Shares Fair Value (in thousands) Balance - December 31, 2015 1,398 $ 31.97 Granted 1,166 17.59 Vested (349) 32.73 Forfeited (266) 27.31 Balance - December 31, 2016 1,949 23.85 Granted 674 29.22 Performance award adjustments (25) 20.95 Assumed from Ultratech 338 31.75 Vested (831) 27.67 Forfeited (225) 26.29 Balance - December 31, 2017 1,880 25.41 Granted 1,257 17.37 Performance award adjustments (5) 32.67 Vested (523) 26.39 Forfeited (391) 24.66 Balance - December 31, 2018 2,218 20.74 The total fair value of shares that vested during the years ended December 31, 2018, 2017, and 2016 was $9.1 million, $22.3 million, and $7.5 million, respectively. For performance awards, the final number of shares earned will vary depending on the achievement of the actual results relative to the performance or market conditions. Each performance award is included in the table above at the grant date target share amount until the end of the performance period if not previously forfeited. The fair value of performance awards with market conditions is estimated on the date of grant using a Monte Carlo simulation. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by employees who receive these awards. The weighted average fair value and the assumptions used in calculating such values during fiscal year 2018 for performance awards with market conditions were based on estimates at the date of grant as follows: Year ended December 31, 2018 Weighted average fair value $ 15.58 Dividend yield 0 % Expected volatility factor (1) 49 % Risk-free interest rate (2) 2.88 % Expected life (in years) (3) 3.0 (1) Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term. (2) The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant. (3) The expected life is the number of years the Company estimates that the awards will be outstanding prior to exercise. Employee Stock Purchase Plan For the years ended December 31, 2018, 2017, and 2016 the Company received cash proceeds of $3.1 million, $2.6 million, and $1.2 million, and issued shares of 332,096, 163,000, and 83,000, respectively, under the ESPP Plan. The weighted average estimated values of employee purchase rights as well as the weighted average assumptions that were used in calculating such values during fiscal years 2018, 2017, and 2016 were based on estimates at the date of grant as follows: Year ended December 31, 2018 2017 2016 Weighted average fair value $ 4.94 $ 7.09 $ 4.45 Dividend yield 0 % 0 % 0 % Expected volatility factor (1) 62 % 36 % 43 % Risk-free interest rate (2) 1.81 % 0.99 % 0.35 % Expected life (in years) (3) 0.5 0.5 0.5 (1) Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term. (2) The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant. (3) The expected life is the number of years the Company estimates that the purchase rights will be outstanding prior to exercise. |
Retirement Plans
Retirement Plans | 12 Months Ended |
Dec. 31, 2018 | |
Retirement Plans | |
Retirement Plans | Note 16 — Retirement Plans The Company maintains a defined contribution plan for the benefit of its U.S. employees. The plan is intended to be tax qualified and contains a qualified cash or deferred arrangement as described under Section 401(k) of the Internal Revenue Code. Eligible participants may elect to contribute a percentage of their base compensation, and the Company may make matching contributions, generally equal to fifty cents for every dollar employees contribute, up to the lesser of three percent of the employee’s eligible compensation or three percent of the maximum the employee is permitted to contribute under then current Internal Revenue Code limitations. Generally, the plan calls for vesting in the Company contributions over the initial five years of a participant’s employment. In addition, the Company assumed Ultratech’s 401(k) plan as a result of the merger, and Ultratech’s plan was merged into the Company’s existing plan effective January 1, 2018. The Company provided employer contributions associated with these plans of approximately $3.0 million, $2.7 million, and $2.6 million for the years ended December 31, 2018, 2017, and 2016, respectively. During 2016, the Company finalized the process to terminate a defined benefit plan it had acquired in the year 2000. The plan had been frozen as of September 30, 1991, and no further benefits had been accrued by participants since that date. In connection with the termination, responsibility for the payment of benefits under the plan was transferred to an insurance company. As a result, the Company reclassified the minimum pension liability of $0.9 million, net of a tax benefit of $0.4 million, from “Accumulated other comprehensive income” in the Consolidated Balance Sheets to “Other, net” in the Consolidated Statements of Operations. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2018 | |
Income Taxes | |
Income Taxes | Note 17 — Income Taxes The amounts of income (loss) before income taxes attributable to domestic and foreign operations were as follows: Year ended December 31, 2018 2017 2016 (in thousands) Domestic $ (286,561) $ (101,573) $ (123,089) Foreign (147,273) 12,583 3,885 Total $ (433,834) $ (88,990) $ (119,204) Significant components of the expense (benefit) for income taxes consisted of the following: Year ended December 31, 2018 2017 2016 (in thousands) Current: Federal $ (1,682) $ — $ — Foreign 2,518 (2,246) 1,937 State and local 38 15 (111) Total current expense (benefit) for income taxes 874 (2,231) 1,826 Deferred: Federal 205 (35,912) 1,459 Foreign (27,932) 1,291 (589) State and local 107 (742) 127 Total deferred expense (benefit) for income taxes (27,620) (35,363) 997 Total expense (benefit) for income taxes $ (26,746) $ (37,594) $ 2,823 The income tax expense was reconciled to the tax expense computed at the U.S. federal statutory tax rate as follows: Year ended December 31, 2018 2017 2016 (in thousands) Income tax expense (benefit) at U.S. statutory rates $ (91,105) $ (31,147) $ (41,722) State taxes, net of U.S. federal impact (2,848) (2,523) (1,963) Effect of international operations 11,847 10,158 8,798 Research and development tax credit (2,230) 620 (801) Net change in valuation allowance 7,747 1,883 50,544 Change in accrual for unrecognized tax benefits 2,868 (4,772) (1,700) Subsidiary liquidation — — (12,435) Share-based compensation 1,848 99 2,133 Effect of 2017 Tax Act (1,690) (11,344) — Asset impairment 46,872 — — Other (55) (568) (31) Total expense (benefit) for income taxes $ (26,746) $ (37,594) $ 2,823 The Company recognized the income tax effects of the 2017 Tax Act in its 2017 financial statements in accordance with SAB 118, which provided SEC staff guidance for the application of ASC 740 in the reporting period in which the 2017 Tax Act was signed into law. As such, the Company’s 2017 financial results included provisional amounts for specific income tax effects of the 2017 Tax Act for which the accounting under ASC 740 was incomplete but for which a reasonable estimate could be determined. During the year ended December 31, 2018, the Company finalized the accounting for the tax effects of 2017 Tax Act based on legislative updates currently available and recorded an additional income tax benefit of $1.7 million for alternative minimum tax credits that became refundable in accordance with the 2017 Tax Act. The Company also reported an increase in deferred tax assets of $6.8 million as a result of adjustments to tax attributes utilized for one-time transition tax, which was offset by a full valuation allowance. The most significant impacts of the 2017 Tax Act on the Company’s federal income taxes for the year ended December 31, 2017 were as follows: Reduction of the U.S. Corporate Income Tax Rate The Company measures deferred tax assets and liabilities using enacted tax rates that will apply in the years in which the temporary differences are expected to be recovered or paid. Accordingly, the Company’s deferred tax assets and liabilities were re-measured as of December 22, 2017 to reflect the reduction in the U.S. corporate income tax rate from 35 percent to 21 percent. The Company recorded an income tax benefit of $4.8 million for the year ended December 31, 2017, as the net deferred tax assets were reduced by $25.6 million with a corresponding valuation allowance reduction of $30.4 million. One-Time Transition Tax on Foreign Earnings As of December 31, 2017, the Company had $180.1 million of foreign earnings that was subject to the one-time transition tax. The Company used its 2017 and carryforward net operating losses to offset the impact of the transition tax. As the Company maintains a full valuation allowance against its U.S. deferred tax assets, the Company did not record an income tax expense related to the transition tax for the year ended December 31, 2017. Valuation Allowance The 2017 Tax Act modified the Net Operating Loss ("NOL") provisions to provide for an indefinite carryforward of NOLs arising in tax years beginning after December 31, 2017. The 2017 Tax Act also limits the amount of NOL deductions that can be used in any one year to 80 percent of the taxpayer’s taxable income, effective with respect to NOLs arising in tax years beginning after December 31, 2017. The Company recognized an income tax benefit of $6.5 million for the year ended December 31, 2017 related to a reduction in the Company’s valuation allowance as a result of the Company scheduling out the reversals of its net deferred tax assets which resulted in tax amortization on indefinite-lived intangible assets becoming available to offset existing deferred tax assets that are now expected to have an indefinite life. Deferred income taxes reflect the effect of temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting purposes and the amounts recognized for tax purposes. The tax effects of the temporary differences were as follows: December 31, 2018 2017 (in thousands) Deferred tax assets: Inventory valuation $ 8,943 $ 8,007 Net operating losses 67,787 73,458 Credit carry forwards 52,592 34,966 Warranty and installation accruals 1,695 1,690 Share-based compensation 6,981 7,385 Other 2,182 1,832 Total deferred tax assets 140,180 127,338 Valuation allowance (114,955) (100,456) Net deferred tax assets 25,225 26,882 Deferred tax liabilities: Purchased intangible assets 15,401 45,807 Convertible Senior Notes 11,265 13,534 Depreciation 2,380 1,339 Total deferred tax liabilities 29,046 60,680 Net deferred taxes $ (3,821) $ (33,798) The Company is no longer permanently reinvesting future earnings from certain foreign jurisdictions and has accrued for foreign tax withholdings of $0.6 million on its unremitted earnings as of December 31, 2018. At December 31, 2018, the Company had U.S. federal NOL carryforwards of approximately $281.4 million, of which $16.0 million has an indefinite carryforward period, with the remaining expiring in varying amounts between 2024 and 2037, if not utilized. In connection with the Ultratech acquisition, $119.0 million of historical NOL carryforwards were acquired, which are subject to an annual limitation. The Company has $3.5 million of capital loss carryforwards that expire in 2021. At December 31, 2018, the Company had U.S. federal research and development credits of $28.3 million that will expire between 2019 and 2038. The Ultratech acquisition resulted in the carryover of $11.4 million of research and development credit carryforwards, which are subject to an annual limitation. The Company also has $9.4 million of foreign tax credits that expire in 2027. Additionally, the Company has state and local NOL carryforwards of approximately $147.6 million (a net deferred tax asset of $9.0 million, net of federal tax benefits and before the valuation allowance) that will expire between 2019 and 2038. Finally, the Company has state credits of $27.4 million, some of which are indefinite and others that will expire between 2019 and 2033. The Company makes assessments to estimate if sufficient taxable income will be generated in the future to use existing deferred tax assets. As of December 31, 2018, the Company continued to have a cumulative three year loss with respect to its U.S. operations. As such, the Company has recorded a valuation allowance against its U.S. deferred tax assets. During 2018, the Company’s valuation allowance increased by approximately $14.5 million, including an increase of $6.8 million as a result of adjustments to tax attributes utilized for one-time transition tax. A roll-forward of the Company’s uncertain tax positions for all U.S. federal, state, and foreign tax jurisdictions was as follows: December 31, 2018 2017 2016 (in thousands) Balance at beginning of year $ 8,269 $ 7,452 $ 9,152 Additions for tax positions related to current year 2,154 511 1,038 Additions for tax positions related to prior years 1,721 3 233 Reductions for tax positions related to prior years (934) (4,877) (2,826) Reductions due to the lapse of the statute of limitations (26) (122) (39) Settlements (47) (287) (106) Additions for business combination — 5,589 — Balance at end of year $ 11,137 $ 8,269 $ 7,452 If the amount of unrecognized tax benefits at December 31, 2018 were recognized, the Company’s income tax provision would decrease by $1.5 million. The gross amount of interest and penalties accrued in income tax payable in the Consolidated Balance Sheets was approximately $0.3 million at both December 31, 2018 and 2017. The Company, or one of its subsidiaries, files income tax returns in the United States federal jurisdiction, and various state, local, and foreign jurisdictions. All material consolidated federal income tax matters have been concluded for years through 2015 subject to subsequent utilization of NOLs generated in such years. All material state and local income tax matters have been reviewed through 2012. The majority of the Company’s foreign jurisdictions have been reviewed through 2015. The Company’s major foreign jurisdictions’ statutes of limitation remain open with respect to the tax years 2017 for China, 2015 through 2017 for Germany and Singapore, and 2017 for Taiwan. The Company does not anticipate that its uncertain tax position will change significantly within the next twelve months subject to the completion of the ongoing tax audits and any resultant settlement. |
Segment Reporting and Geographi
Segment Reporting and Geographic Information | 12 Months Ended |
Dec. 31, 2018 | |
Segment Reporting and Geographic Information | |
Segment Reporting and Geographic Information | Note 18 — Segment Reporting and Geographic Information The Company operates and measures its results in one operating segment and therefore has one reportable segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices. The Company’s Chief Operating Decision Maker, the Chief Executive Officer, evaluates performance of the Company and makes decisions regarding the allocation of resources based on total Company results. Sales by market is as follows: For the year ended December 31, 2018 2017 2016 (in thousands) Sales by end-market Advanced Packaging, MEMS & RF Filters $ 90,775 $ 67,406 $ 67,484 LED Lighting, Display & Compound Semiconductor 249,974 248,615 145,701 Front-End Semiconductor 62,582 40,319 8,427 Scientific & Industrial 138,751 119,346 110,090 Total $ 542,082 $ 475,686 $ 331,702 The Company’s significant operations outside the United States include sales and service offices in China, Europe, and Rest of World. For geographic reporting, sales are attributed to the location in which the customer facility is located. Sales and long-lived tangible assets by geographic region are as follows: Net Sales to Unaffiliated Customers Long-lived Tangible Assets 2018 2017 2016 2018 2017 2016 (in thousands) United States $ 125,659 $ 93,433 $ 85,582 $ 78,503 $ 81,046 $ 60,012 China 194,032 106,674 84,604 81 64 219 EMEA (1) 89,102 72,979 84,181 205 231 93 Rest of World 133,289 202,600 77,335 1,495 3,717 322 Total $ 542,082 $ 475,686 $ 331,702 $ 80,284 $ 85,058 $ 60,646 (1) EMEA consists of Europe, the Middle East, and Africa |
Selected Quarterly Financial In
Selected Quarterly Financial Information (unaudited) | 12 Months Ended |
Dec. 31, 2018 | |
Selected Quarterly Financial Information (unaudited) | |
Selected Quarterly Financial Information (unaudited) | Note 19 — Selected Quarterly Financial Information (unaudited) The following table presents selected unaudited financial data for each fiscal quarter of 2018 and 2017. Although unaudited, this information has been prepared on a basis consistent with the Company’s audited Consolidated Financial Statements and, in the opinion of management, reflects all adjustments (consisting only of normal recurring adjustments) that are considered necessary for a fair presentation of this information in accordance with GAAP. Such quarterly results are not necessarily indicative of future results of operations. Fiscal 2018 Fiscal 2017 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 (in thousands, except per share amounts) Net sales $ 158,574 $ 157,779 $ 126,757 $ 98,972 $ 94,499 $ 112,218 $ 129,308 $ 139,661 Gross profit 56,680 55,395 46,385 35,259 34,500 35,847 50,529 55,352 Net income (loss) (15,827) (237,634) (8,953) (144,674) 1,640 (20,817) (23,740) (8,479) Basic income (loss) per common share (0.34) (5.02) (0.19) (3.11) 0.04 (0.49) (0.51) (0.18) Diluted income (loss) per common share (0.34) (5.02) (0.19) (3.11) 0.04 (0.49) (0.51) (0.18) Acquisition of Ultratech During the second quarter of 2017, the Company acquired Ultratech. The results of operations of Ultratech have been included in the consolidated financial statements since the date of acquisition. Refer to Note 5, “Business Combinations,” for additional information. Asset Impairments During the second quarter of 2018, the Company recorded non-cash impairment charges related to the Ultratech asset group of $216.4 million and $35.9 million for definite-lived intangible assets and in-process research and development assets, respectively. Additionally, during the fourth quarter of 2018, the Company recorded a non-cash goodwill impairment charge of $122.8 million. Refer to Note 6, “Goodwill and Intangible Assets,” for additional information. |
Schedule II - Valuation and Qua
Schedule II - Valuation and Qualifying Accounts | 12 Months Ended |
Dec. 31, 2018 | |
Schedule II - Valuation and Qualifying Accounts | |
Schedule II - Valuation and Qualifying Accounts | Schedule II — Valuation and Qualifying Accounts Additions Charged Balance at (Credited) Charged to Balance at Beginning to Costs and Other End of Deducted from asset accounts: of Period Expenses Accounts Deductions Period (in thousands) Year ended December 31, 2018 Allowance for doubtful accounts $ 270 $ — $ — $ — $ 270 Valuation allowance in net deferred tax assets 100,456 14,499 — — 114,955 $ 100,726 $ 14,499 $ — $ — $ 115,225 Year ended December 31, 2017 Allowance for doubtful accounts $ 286 $ 99 $ — $ (115) $ 270 Valuation allowance in net deferred tax assets 104,744 (49,589) 45,301 — 100,456 $ 105,030 $ (49,490) $ 45,301 $ (115) $ 100,726 Year ended December 31, 2016 Allowance for doubtful accounts $ 206 $ 171 $ — $ (91) $ 286 Valuation allowance in net deferred tax assets 54,200 50,544 — — 104,744 $ 54,406 $ 50,715 $ — $ (91) $ 105,030 |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2018 | |
Significant Accounting Policies | |
Basis of Presentation | (b) Basis of Presentation The accompanying audited Consolidated Financial Statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”). The Company reports interim quarters on a 13-week basis ending on the last Sunday of each period, which is determined at the start of each year. The Company’s fourth quarter always ends on the last day of the calendar year, December 31. During 2018 the interim quarters ended on April 1, July 1, and September 30, and during 2017 the interim quarters ended on April 2, July 2, and October 1. The Company reports these interim quarters as March 31, June 30, and September 30 in its interim consolidated financial statements. |
Use of Estimates | (c) Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, these estimates may ultimately differ from actual results. Significant items subject to such estimates and assumptions include: (i) stand-alone selling prices for the Company’s products and services; (ii) allowances for doubtful accounts; (iii) inventory obsolescence; (iv) the useful lives and expected future cash flows of property, plant, and equipment and identifiable intangible assets; (v) the fair value of the Company’s reporting unit and related goodwill; (vi) investment valuations and the valuation of derivatives, deferred tax assets, and assets acquired in business combinations; (vii) the recoverability of long-lived assets; (viii) liabilities for product warranty and legal contingencies; (ix) share-based compensation; and (x) income tax uncertainties. Actual results could differ from those estimates. |
Principles of Consolidation | (d) Principles of Consolidation The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Companies acquired during each reporting period are reflected in the results of the Company effective from their respective dates of acquisition through the end of the reporting period. |
Foreign Currencies | (e) Foreign Currencies Assets and liabilities of the Company’s foreign subsidiaries that operate using functional currencies other than the U.S. dollar are translated using the exchange rates in effect at the balance sheet date. Results of operations are translated using monthly average exchange rates. Adjustments arising from the translation of the foreign currency financial statements of the Company’s subsidiaries into U.S. dollars, including intercompany transactions of a long-term nature, are reported as currency translation adjustments in “Accumulated other comprehensive income” in the Consolidated Balance Sheets. Foreign currency transaction gains or losses are included in “Other, net” in the Consolidated Statements of Operations. |
Revenue recognition | (f) Revenue Recognition Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another. When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach. Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met. In certain cases the Company’s contracts with customers contain a billing retention, typically 10% of the sales price, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets. The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement. The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected amortization period is one year or less. The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in cost of services when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue. |
Warranty Costs | (g) Warranty Costs The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance by providing labor and parts necessary to repair the systems during the warranty period. The Company accounts for the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of sales” in the Consolidated Statements of Operations. The estimated warranty cost is based on the Company’s historical experience with its systems and regional labor costs. The Company calculates the average service hours by region and parts expense per system utilizing actual service records to determine the estimated warranty charge. The Company updates its warranty estimates on a quarterly basis when the actual product performance or field expense differs from original estimates. |
Shipping and Handling Costs | (h) Shipping and Handling Costs Shipping and handling costs are expenses incurred to move, package, and prepare the Company’s products for shipment and to move the products to a customer’s designated location. These costs are generally comprised of payments to third-party shippers. Shipping and handling costs are included in “Cost of sales” in the Consolidated Statements of Operations. |
Research and Development Costs | (i) Research and Development Costs Research and development costs are expensed as incurred and include charges for the development of new technology and the transition of existing technology into new products or services. |
Advertising Expense | (j) Advertising Expense The cost of advertising is expensed as incurred and totaled $0.9 million, $0.9 million, and $0.8 million for the years ended December 31, 2018, 2017, and 2016, respectively. |
Accounting for Share-Based Compensation | (k) Accounting for Share-Based Compensation Share-based awards exchanged for employee services are accounted for under the fair value method. Accordingly, share-based compensation cost is measured at the grant date based on the fair value of the award. The expense for awards is recognized over the employee’s requisite service period (generally the vesting period of the award). The Company has elected to treat awards with only service conditions and with graded vesting as one award. Consequently, the total compensation expense is recognized straight-line over the entire vesting period, so long as the compensation cost recognized at any date at least equals the portion of the grant date fair value of the award that is vested at that date. In addition to stock options, restricted share awards (“RSAs”) and restricted stock units (“RSUs”) with time-based vesting, the Company grants performance share units and awards (“PSUs” and “PSAs”) that have either performance or market conditions. Compensation cost for PSUs and PSAs with performance conditions is recognized over the requisite service period based on the timing and expected level of achievement of the performance targets. A change in the assessment of performance attainment prior to the conclusion of the performance period is recognized in the period of the change in estimate. Compensation cost for PSUs and PSAs with market conditions is recognized over the requisite service period regardless of the expected level of achievement. For all PSUs and PSAs, the number of shares issued to the employee at the conclusion of the service period may vary from the original target based upon the level of attainment of the performance or market conditions. The Company uses the Black-Scholes option-pricing model to compute the estimated fair value of option awards and purchase rights under the Employee Stock Purchase Plan. The Company uses a Monte Carlo simulation to compute the estimated fair value of awards with market conditions. The Black-Scholes model and Monte Carlo simulation include assumptions regarding dividend yields, expected volatility, expected option term, and risk-free interest rates. See Note 15, “Stock Plans,” for additional information. See Note 1(t), “Recently Adopted Accounting Standards,” for additional information concerning the Company’s adoption of Accounting Standards Update (“ASU”) 2016-09: Stock Compensation: Improvements to Employee Share-Based Payment Accounting . |
Income Taxes | (l) Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rate is recognized in income in the period that includes the enactment date. On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “2017 Tax Act”), which made broad and complex changes to the U.S. tax code. In response to the 2017 Tax Act, the SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) which provided guidance on accounting for the tax effects of 2017 Tax Act, including addressing any uncertainty or diversity of view in applying ASC 740, Income Taxes (“ASC 740”), in the reporting period in which the 2017 Tax Act was enacted. In addition, SAB 118 provided a measurement period that should not extend beyond one year from the 2017 Tax Act enactment date for companies to complete the accounting under ASC 740. During the year ended December 31, 2018, the Company finalized the accounting for the tax effects of 2017 Tax Act. In January 2018, the FASB released guidance on the accounting for taxes under the global intangible low-taxed income (“GILTI”) provisions of the 2017 Tax Act. The GILTI provisions impose a tax on foreign income in excess of a deemed return on tangible assets of foreign operations. The Company has made a policy election to account for income taxes incurred under GILTI as a period cost. |
Concentration of Credit Risk | (m) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, investments, derivative financial instruments used in hedging activities, and accounts receivable. The Company invests in a variety of financial instruments and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material credit losses on its investments. The Company maintains an allowance reserve for potentially uncollectible accounts for estimated losses resulting from the inability of its customers to make required payments. The Company evaluates its allowance for doubtful accounts based on a combination of factors. In circumstances where specific invoices are deemed to be uncollectible, the Company provides a specific allowance for bad debt against the amount due to reduce the net recognized receivable to the amount reasonably expected to be collected. The Company also provides allowances based on its write-off history. The allowance for doubtful accounts totaled $0.3 million at December 31, 2018 and 2017. To further mitigate the Company’s exposure to uncollectable accounts, the Company may request certain customers provide a negotiable irrevocable letter of credit drawn on a reputable financial institution. These irrevocable letters of credit are typically issued to mature between zero and 90 days from the date the documentation requirements are met, typically when a system ships or upon receipt of final acceptance from the customer. The Company, at its discretion, may monetize these letters of credit on a non-recourse basis after they become negotiable but before maturity. The fees associated with the monetization are included in “Selling, general, and administrative” in the Consolidated Statements of Operations and were immaterial for the years ended December 31, 2018, 2017, and 2016. |
Fair Value of Financial Instruments | (n) Fair Value of Financial Instruments The carrying amounts of financial instruments, including cash equivalents, accounts receivable, accounts payable, and accrued expenses reflected in the consolidated financial statements approximate fair value due to their short-term maturities. The fair value of debt for footnote disclosure purposes, including current maturities, if any, is estimated using recently quoted market prices of the instrument, or if not available, a discounted cash flow analysis based on the estimated current incremental borrowing rates for similar types of instruments. |
Cash, Cash Equivalents, and Short-Term Investments | (o) Cash, Cash Equivalents, and Short-Term Investments All financial instruments purchased with an original maturity of three months or less at the time of purchase are considered cash equivalents. Such items may include liquid money market funds, certificate of deposit and time deposit accounts, U.S. treasuries, government agency securities, and corporate debt. Investments that are classified as cash equivalents are carried at cost, which approximates fair value. The Company’s cash and cash equivalents includes $69.6 million and $76.7 million of cash equivalents at December 31, 2018 and 2017, respectively. A portion of the Company’s cash and cash equivalents is held by its subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar. Approximately 32% and 77% of cash and cash equivalents were maintained outside the United States at December 31, 2018 and 2017, respectively. Marketable debt securities are generally classified as available-for-sale for use in current operations, if required, and are reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income.” These securities can include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other, net” in the Consolidated Statements of Operations. The specific identification method is used to determine the realized gains and losses on investments. Non-marketable equity securities are equity securities without readily observable market prices and are included in “Other assets” in the Consolidated Balance Sheets. Non-marketable securities are measured at cost, adjusted for changes in observable prices minus impairment. Changes in fair value are included in “Other, net” in the Consolidated Statements of Operations. |
Inventories | (p) Inventories Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. Estimates of net realizable value include, but are not limited to, management’s forecasts related to the Company’s future manufacturing schedules, customer demand, technological and/or market obsolescence, general market conditions, possible alternative uses, and the ultimate realization of excess inventory. If future customer demand or market conditions are less favorable than the Company’s projections, additional inventory write-downs may be required and would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition. See Note 5, “Business Combinations,” for additional information. |
Business Combinations | (q) Business Combinations The Company allocates the fair value of the purchase consideration of the Company’s acquisitions to the tangible assets, intangible assets, including in-process research and development (“IPR&D”), if any, and liabilities assumed, based on estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. See Note 5, “Business Combinations,” for additional information. |
Goodwill and Indefinite-Lived Intangibles | (r) Goodwill and Indefinite-Lived Intangible Assets Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is measured as the excess of the consideration transferred over the net fair value of identifiable assets acquired and liabilities assumed. Intangible assets with indefinite useful lives are measured at their respective fair values on the acquisition date. Intangible assets related to IPR&D projects are considered to be indefinite-lived until the completion or abandonment of the associated R&D efforts. If and when development is complete, the associated assets would be deemed long-lived and would then be amortized based on their respective estimated useful lives at that point in time. Goodwill and indefinite-lived intangibles are not amortized into results of operations but instead are evaluated for impairment. The Company performs the evaluation in the beginning of the fourth quarter of each year or more frequently if impairment indicators arise. In testing goodwill for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the reporting unit’s fair value is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the reporting unit to its carrying amount. If the fair value exceeds the carrying amount, goodwill is not impaired. If the carrying amount exceeds fair value, the Company then records an impairment loss equal to the difference, up to the carrying value of goodwill. The Company determines the fair value of its reporting unit based on a reconciliation of the fair value of the reporting unit to the Company’s adjusted market capitalization. The adjusted market capitalization is calculated by multiplying the average share price of the Company’s common stock for the last ten trading days prior to the measurement date by the number of outstanding common shares and adding a control premium. The control premium is estimated using historical transactions in similar industries. In testing indefinite-lived intangible assets for impairment, the Company may first perform a qualitative assessment of whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount, and, if so, the Company then quantitatively compares the fair value of the indefinite-lived intangible asset to its carrying amount. The Company determines the fair value of its indefinite-lived intangible assets using a discounted cash flow method. |
Long-Lived Assets | (s) Long-Lived Assets Long-lived intangible assets consist of purchased technology, customer relationships, patents, trademarks and tradenames, and backlog and are initially recorded at fair value. Long-lived intangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or straight-lined if such pattern cannot be reliably determined. Property, plant, and equipment are recorded at cost. Depreciation expense is calculated based on the estimated useful lives of the assets by using the straight-line method. Amortization of leasehold improvements is recognized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, a recoverability test is performed utilizing undiscounted cash flows expected to be generated by that asset or asset group compared to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, impairment is recognized to the extent the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models or, when available, quoted market values and third-party appraisals. |
Recently Adopted Accounting Standards and Recent Accounting Pronouncements Not Yet Adopted | (t) Recently Adopted Accounting Standards The Company adopted ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”), as of January 1, 2018, using the full retrospective method. All amounts and disclosures set forth in this Form 10-K reflect these changes. The most significant financial statement impacts of adopting ASC 606 are the elimination of the constraint on revenue associated with the billing retention related to the receipt of customer final acceptance and the identification of installation services as a performance obligation. The elimination of the constraint on revenue related to customer final acceptance, which is usually about 10 percent of a system sale, is now generally recognized at the time the Company transfers control of the system to the customer, which is earlier than under the Company’s previous revenue recognition model for certain contracts that were subject to the billing constraint. The performance obligation related to installation services is now recognized as the installation services are performed, which is later than the Company’s previous revenue recognition model. The Company applied ASC 606 retrospectively and elected to use the disclosure exemption in the transition guidance under which the Company does not disclose prior period information regarding the amount of the transaction price allocated to remaining performance obligations. The cumulative effect of the adoption was recognized as a decrease to Accumulated deficit of $6.9 million on January 1, 2016. The following tables summarize the impact of adoption on the Company’s previously reported financial position and results of operations: December 31, 2017 As reported Adjustments As adjusted (in thousands) Balance Sheet Contract assets $ — $ 160 $ 160 Deferred cost of sales 16,060 (66) 15,994 Deferred income taxes 2,953 94 3,047 Accrued expenses and other current liabilities 60,339 (2,271) 58,068 Customer deposits and deferred revenue 108,953 3,079 112,032 Additional paid-in capital 1,053,079 (1,126) 1,051,953 Accumulated deficit (213,376) 506 (212,870) Year ended December 31, 2017 2016 As reported Adjustments As adjusted As reported Adjustments As adjusted (in thousands, except per share amounts) Statement of Operations Net sales $ 484,756 $ (9,070) $ 475,686 $ 332,451 $ (749) $ 331,702 Cost of sales 300,438 (980) 299,458 199,593 (989) 198,604 Income tax expense (benefit) (36,107) (1,487) (37,594) 2,766 57 2,823 Net income (loss) (44,793) (6,603) (51,396) (122,210) 183 (122,027) Diluted earnings (loss) per share (1.01) (0.15) (1.16) (3.11) 0.01 (3.10) The Company’s adoption of the standard had no impact to cash provided by or used in operating, investing, or financing activities on the Consolidated Statements of Cash Flows. The Company adopted ASU 2016-01, Financial Instruments – Overall , as of January 1, 2018. This ASU requires certain equity investments to be measured at fair value, with changes in fair value recognized in net income. The Company measures equity investments without readily observable market prices at cost, adjusted for changes in observable prices minus impairment. Changes in measurement are included in “Other, net” in the Consolidated Statements of Operations. This ASU has not had a material impact on the consolidated financial statements upon adoption, and the Company will monitor its equity investments each reporting period for changes in observable market prices, if any, which may be material in future periods. The Company adopted ASU 2016-09: Stock Compensation: Improvements to Employee Share-Based Payment Accounting , as of January 1, 2016. This ASU simplifies several aspects of the accounting for share-based payments. Beginning in 2016, excess tax benefits and deficiencies are recognized as income tax expense or benefit in the income statement in the reporting period incurred. The Company also made an accounting policy election to account for forfeitures when they occur. The ASU transition guidance requires that this election be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period in which the ASU is adopted. Accordingly, the Company recorded a $1.3 million charge to the opening accumulated deficit balance as of January 1, 2016, with a corresponding adjustment to additional paid-in capital, resulting in no impact to the opening balance of total stockholders’ equity. In addition, the Company recorded additional deferred tax assets with an equally offsetting valuation allowance of $2.4 million. (u) Recent Accounting Pronouncements Not Yet Adopted In February 2016, the FASB issued ASU 2016-02: Leases , which, along with subsequent ASUs related to this topic, has been codified as Accounting Standards Codification 842 (“ASC 842”). ASC 842 generally requires operating lessee rights and obligations to be recognized as assets and liabilities on the balance sheet. The new standard, which is effective for the Company on January 1, 2019, offers a transition option whereby companies can recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption rather than in the earliest period presented. The Company plans to adopt using this transition method. In addition, ASC 842 provides for a number of optional exemptions in transition. The Company expects to elect certain exemptions whereby prior conclusions regarding lease identification, lease classification, and initial direct costs are not required to be reassessed under the new standard. The Company also plans to elect allowable policies whereby the Company will not separate lease and non-lease components, and the Company will not recognize an asset or liability for leases with original terms or renewals of one year or less. Upon adoption, the Company expects to recognize an operating lease liability ranging from $12 million to $16 million based on the present value of remaining minimum rental payments on existing leases, with corresponding assets of approximately the same amount. The Company is also evaluating other pronouncements recently issued but not yet adopted. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements. |
Significant Accounting Polici_3
Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Change in Accounting Principle | |
Summary of impact on adoption of accounting standards on previously reported financial position and results | December 31, 2017 As reported Adjustments As adjusted (in thousands) Balance Sheet Contract assets $ — $ 160 $ 160 Deferred cost of sales 16,060 (66) 15,994 Deferred income taxes 2,953 94 3,047 Accrued expenses and other current liabilities 60,339 (2,271) 58,068 Customer deposits and deferred revenue 108,953 3,079 112,032 Additional paid-in capital 1,053,079 (1,126) 1,051,953 Accumulated deficit (213,376) 506 (212,870) Year ended December 31, 2017 2016 As reported Adjustments As adjusted As reported Adjustments As adjusted (in thousands, except per share amounts) Statement of Operations Net sales $ 484,756 $ (9,070) $ 475,686 $ 332,451 $ (749) $ 331,702 Cost of sales 300,438 (980) 299,458 199,593 (989) 198,604 Income tax expense (benefit) (36,107) (1,487) (37,594) 2,766 57 2,823 Net income (loss) (44,793) (6,603) (51,396) (122,210) 183 (122,027) Diluted earnings (loss) per share (1.01) (0.15) (1.16) (3.11) 0.01 (3.10) |
Income (Loss) Per Share (Tables
Income (Loss) Per Share (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Income (Loss) Per Share | |
Schedule of basic and diluted income (loss) per share and weighted average shares | For the year ended December 31, 2018 2017 2016 (in thousands, except per share amounts) Net income (loss) $ (407,088) $ (51,396) $ (122,027) Net income (loss) per common share: Basic $ (8.63) $ (1.16) $ (3.10) Diluted $ (8.63) $ (1.16) $ (3.10) Basic weighted average shares outstanding 47,151 44,174 39,340 Effect of potentially dilutive share-based awards — — — Diluted weighted average shares outstanding 47,151 44,174 39,340 Unvested participating shares excluded from basic weighted average shares outstanding since the securityholders are not obligated to fund losses 20 72 312 Common share equivalents excluded from the diluted weighted average shares outstanding since Veeco incurred a net loss and their effect would be antidilutive 28 239 107 Potentially dilutive non-participating shares excluded from the diluted calculation as their effect would be antidilutive 2,474 1,744 1,896 Maximum potential shares to be issued for settlement of the Convertible Senior Notes excluded from the diluted calculation as their effect would be antidilutive 8,618 8,618 — |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Fair Value Measurements | |
Schedule of assets measured on a recurring basis at fair value | Level 1 Level 2 Level 3 Total (in thousands) December 31, 2018 Cash equivalents Certificate of deposits and time deposits $ 65,571 $ — $ — $ 65,571 U.S. treasuries 3,990 — — 3,990 Total $ 69,561 $ — $ — $ 69,561 Short-term investments U.S. treasuries $ 37,184 $ — $ — $ 37,184 Corporate debt — 8,516 — 8,516 Commercial paper — 2,489 — 2,489 Total $ 37,184 $ 11,005 $ — $ 48,189 December 31, 2017 Cash equivalents Certificate of deposits and time deposits $ 64,249 $ — $ — $ 64,249 U.S. treasuries 12,490 — — 12,490 Total $ 76,739 $ — $ — $ 76,739 Short-term investments U.S. treasuries $ 33,895 $ — $ — $ 33,895 Corporate debt — 10,886 — 10,886 Commercial paper — 2,999 — 2,999 Total $ 33,895 $ 13,885 $ — $ 47,780 |
Investments (Tables)
Investments (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Investments | |
Schedule of amortized cost and fair value of available-for-sale securities | Gross Gross Amortized Unrealized Unrealized Estimated Cost Gains Losses Fair Value (in thousands) December 31, 2018 U.S. treasuries $ 37,191 $ — $ (7) $ 37,184 Corporate debt 8,525 — (9) 8,516 Commercial paper 2,489 — — 2,489 Total $ 48,205 $ — $ (16) $ 48,189 December 31, 2017 U.S. treasuries $ 33,914 $ — $ (19) $ 33,895 Corporate debt 10,894 — (8) 10,886 Commercial paper 2,999 — — 2,999 Total $ 47,807 $ — $ (27) $ 47,780 |
Schedule of fair value and unrealized losses of available-for-sale securities in a loss position | December 31, 2018 December 31, 2017 Gross Gross Estimated Unrealized Estimated Unrealized Fair Value Losses Fair Value Losses (in thousands) U.S. treasuries $ 37,184 $ (7) $ 33,895 $ (19) Corporate debt 8,516 (9) 10,886 (8) Total $ 45,700 $ (16) $ 44,781 $ (27) |
Business Combinations (Tables)
Business Combinations (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Business Combinations | |
Schedule of acquisition date fair value of the consideration transferred net of cash acquired | Acquisition Date (May 26, 2017) (in thousands) Cash consideration, net of cash acquired of $229.4 million $ 404,490 Equity consideration (7.2 million shares issued) 228,643 Replacement equity awards attributable to pre-acquisition service 228 Acquisition date fair value $ 633,361 |
Summary of the estimated fair values of the assets acquired, net of cash acquired, and liabilities assumed | Acquisition Date (May 26, 2017) (in thousands) Short-term investments $ 47,161 Accounts receivable 45,465 Inventories 59,100 Deferred cost of sales 242 Prepaid expense and other current assets 7,217 Property, plant, and equipment 18,152 Intangible assets 346,940 Other assets 6,442 Total identifiable assets acquired 530,719 Accounts payable 24,291 Accrued expenses and other current liabilities 16,356 Customer deposits and deferred revenue 4,834 Deferred income taxes 32,478 Other liabilities 11,622 Total liabilities assumed 89,581 Net identifiable assets acquired 441,138 Goodwill 192,223 Net assets acquired $ 633,361 |
Schedule of classes of intangible assets acquired and the estimated weighted-average useful life of each class | Acquisition Date (May 26, 2017) Amount Useful life (in thousands) Technology $ 158,390 9 years Customer relationships 116,710 12 years Backlog 3,080 6 months In-process research and development 43,340 * Trademark and tradenames 25,420 7 years Intangible assets acquired $ 346,940 * In-process research and development will be amortized (or impaired) upon completion (or abandonment) of the development project. |
Schedule of amounts of revenue and income (loss) from continuing operations before income taxes | Year ended December 31, 2017 (in thousands) Net sales $ 65,280 Loss before income taxes $ (62,284) |
Schedule of pro forma financial information | For the year ended December 31, 2017 2016 (in thousands, except per share amounts) Net sales $ 546,428 $ 525,752 Loss before income taxes (90,000) (217,783) Diluted earnings per share $ (1.38) $ (4.67) |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Goodwill and Intangible Assets | |
Schedule of changes in goodwill | Gross carrying Accumulated amount impairment Net amount (in thousands) Balance at December 31, 2016 $ 238,108 $ 123,200 $ 114,908 Acquisition 192,223 — 192,223 Balance at December 31, 2017 430,331 123,200 307,131 Impairment — 122,829 (122,829) Balance at December 31, 2018 $ 430,331 $ 246,029 $ 184,302 |
Schedule of intangible assets excluding goodwill | December 31, 2018 December 31, 2017 Weighted Average Accumulated Accumulated Remaining Gross Amortization Gross Amortization Amortization Carrying and Net Carrying and Net Period Amount Impairment Amount Amount Impairment Amount (in years) (in thousands) Technology 6.4 $ 337,218 $ 290,808 $ 46,410 $ 307,588 $ 133,121 $ 174,467 Customer relationships 10.2 164,595 136,126 28,469 164,595 39,336 125,259 In-process R&D — 13,710 10,530 3,180 43,340 — 43,340 Trademarks and tradenames 5.4 30,910 23,899 7,011 30,910 4,321 26,589 Other 1.3 3,686 3,607 79 3,686 3,498 188 Total 7.3 $ 550,119 $ 464,970 $ 85,149 $ 550,119 $ 180,276 $ 369,843 |
Schedule of estimated annual amortization expense, excluding in-process R&D for intangible assets with definite useful lives | Amortization (in thousands) 2019 $ 16,820 2020 15,894 2021 12,772 2022 10,438 2023 8,675 Thereafter 17,370 Total $ 81,969 |
Inventories (Tables)
Inventories (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Inventories | |
Schedule of inventories | December 31, 2018 2017 (in thousands) Materials $ 90,816 $ 59,919 Work-in-process 42,354 37,222 Finished goods 23,141 23,125 Total $ 156,311 $ 120,266 |
Property, Plant, and Equipmen_2
Property, Plant, and Equipment and Assets Held for Sale (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Property, Plant, and Equipment and Assets Held for Sale | |
Schedule of property, plant, and equipment | December 31, 2018 2017 Average Useful Life (in thousands) Land $ 5,669 $ 5,669 N/A Building and improvements 61,124 54,449 10 – 40 years Machinery and equipment (1) 128,385 126,829 3 – 10 years Leasehold improvements 9,033 10,073 3 – 7 years Gross property, plant, and equipment 204,211 197,020 Less: accumulated depreciation and amortization 123,927 111,962 Net property, plant, and equipment $ 80,284 $ 85,058 (1) Machinery and equipment also includes software, furniture, and fixtures |
Accrued Expenses and Other Li_2
Accrued Expenses and Other Liabilities (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Accrued Expenses and Other Liabilities | |
Schedule of accrued expenses and other current liabilities | December 31, 2018 2017 (in thousands) Payroll and related benefits $ 20,486 $ 32,996 Warranty 7,852 6,532 Interest 4,321 4,430 Professional fees 2,897 3,942 Merger consideration payable — 2,662 Sales, use, and other taxes 2,670 2,144 Restructuring liability 2,213 1,520 Other 6,011 3,842 Total $ 46,450 $ 58,068 |
Schedule of changes in deferred revenue | (in thousands) Balance - December 31, 2017 $ 70,536 Deferral of revenue 10,251 Recognition of previously deferred revenue (36,372) Balance - December 31, 2018 $ 44,415 |
Restructuring Charges (Tables)
Restructuring Charges (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Restructuring Charges | |
Schedule of restructuring accrual activities | Personnel Facility Severance and Related Costs Related Costs and Other Total (in thousands) Balance - December 31, 2015 $ 824 $ — $ 824 Provision 4,544 1,098 5,642 Changes in estimate (2) — (2) Payments (3,570) (1,098) (4,668) Balance - December 31, 2016 1,796 — 1,796 Provision 4,714 5,257 9,971 Payments (4,990) (5,257) (10,247) Balance - December 31, 2017 1,520 — 1,520 Provision 4,681 2,714 7,395 Payments (4,058) (2,644) (6,702) Balance - December 31, 2018 $ 2,143 $ 70 $ 2,213 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Commitments and Contingencies | |
Schedule of changes in product warranty reserves | December 31, 2018 2017 2016 (in thousands) Balance, beginning of the year $ 6,532 $ 4,217 $ 8,159 Warranties issued 6,737 5,817 3,916 Addition from Ultratech acquisition — 1,889 — Consumption of reserves (6,573) (6,330) (6,433) Changes in estimate 1,156 939 (1,425) Balance, end of the year $ 7,852 $ 6,532 $ 4,217 |
Schedule of future minimum lease payments under non-cancelable operating leases (exclusive of renewal options) | Minimum lease commitments at December 31, 2018 for property and equipment under operating lease agreements (exclusive of renewal options) are payable as follows: Operating Leases (in thousands) Payments due by period: 2019 $ 5,143 2020 5,056 2021 2,432 2022 1,812 2023 1,066 Thereafter 548 Total $ 16,057 |
Schedule of customers who accounted for more than 10% of our aggregate accounts receivable or net sales | Accounts Receivable Net Sales December 31, For the Year Ended December 31, Customer 2018 2017 2018 2017 2016 Customer A * 24 % * 21 % 14 % Customer B 22 % * * * * Customer C * * 12 % * * * Less than 10% of aggregate accounts receivable or net sales |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Debt | |
Schedule of carrying value of Convertible Senior Notes | December 31, 2018 2017 (in thousands) Principal amount $ 345,000 $ 345,000 Unamortized debt discount (52,336) (63,022) Unamortized transaction costs (5,272) (6,348) Net carrying value $ 287,392 $ 275,630 |
Schedule of interest expense related to Convertible Senior Notes | For the year ended December 31, 2018 2017 (in thousands) Cash Interest Expense Coupon interest expense $ 9,315 $ 8,901 Non-Cash Interest Expense Amortization of debt discount 10,686 9,490 Amortization of transaction costs 1,076 956 Total Interest Expense $ 21,077 $ 19,347 |
Derivative Financial Instrume_2
Derivative Financial Instruments (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Derivative Financial Instruments | |
Schedule of notional amount and fair value of derivatives | December 31, 2017 Fair Value Maturity Dates Notional Amount (in thousands) Foreign currency exchange forwards $ — January 2018 $ 622 |
Schedule of gains and (losses) and weighted average notional amount of derivatives | Year ended December 31, 2018 2017 2016 Gains (losses) Weighted average notional amount Gains (losses) Weighted average notional amount Gains (losses) Weighted average notional amount (in thousands) Foreign currency exchange forwards $ 327 2,869 $ (6) 314 $ 219 7,175 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Equity | |
Schedule of the changes in the balances of each component of AOCI, net of tax | Unrealized Gains (Losses) Foreign Minimum on Available Currency Pension for Sale Translation Liability Securities Total (in thousands) Balance - December 31, 2015 $ 2,246 $ (866) $ (32) $ 1,348 Other comprehensive income (loss), before reclassifications (19) — (6) (25) Amounts reclassified from AOCI (430) 866 18 454 Other comprehensive income (loss) (449) 866 12 429 Balance - December 31, 2016 1,797 — (20) 1,777 Other comprehensive income (loss) 42 — (7) 35 Balance - December 31, 2017 1,839 — (27) 1,812 Other comprehensive income (loss) (3) — 11 8 Balance - December 31, 2018 $ 1,836 $ — $ (16) $ 1,820 |
Stock Plans (Tables)
Stock Plans (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Stock Plans | |
Schedule of share-based compensation expense | For the year ended December 31, 2018 2017 2016 (in thousands) Cost of sales $ 1,885 $ 2,505 $ 1,956 Research and development 3,611 2,957 3,324 Selling, general, and administrative 9,417 12,851 10,433 Restructuring 1,161 1,880 — Acquisition costs — 4,203 — Total $ 16,074 $ 24,396 $ 15,713 |
Summary of unrecognized share-based compensation costs | Unrecognized Weighted Share-Based Average Period Compensation Expected to be Costs Recognized (in thousands) (in years) Stock option awards $ — — Restricted stock units 2,466 2.4 Restricted stock awards 19,663 2.6 Performance share units 7,356 2.4 Total unrecognized share-based compensation cost $ 29,485 2.5 |
Schedule of options, vested and expected to vest | Weighted Number Weighted Average Aggregate of Average Remaining Intrinsic Shares Exercise Price Contractual Life Value (in thousands) (in years) (in thousands) Vested 1,222 $ 34.80 3.0 — Expected to vest — — — — Total 1,222 34.80 3.0 — |
Summary of stock option activity | Weighted Number of Average Shares Exercise Price (in thousands) Balance - December 31, 2015 2,064 $ 32.91 Granted — — Exercised (194) 12.18 Expired or forfeited (294) 34.44 Balance - December 31, 2016 1,576 35.18 Granted — — Exercised (18) 30.03 Expired or forfeited (164) 37.47 Balance - December 31, 2017 1,394 34.97 Granted — — Exercised — — Expired or forfeited (172) 36.21 Balance - December 31, 2018 1,222 34.80 |
Summary of information about stock option information | Options Outstanding Options Exercisable Weighted Weighted Aggregate Average Weighted Aggregate Average Weighted Intrinsic Remaining Average Intrinsic Remaining Average Range of Exercise Prices Shares Value Contractual Life Exercise Price Shares Value Contractual Life Exercise Price (in thousands) (in thousands) (in years) (in thousands) (in thousands) (in years) $20.00 - $30.00 25 $ — 3.6 $ 28.13 25 $ — 3.6 $ 28.13 $30.01 - $40.00 1,058 — 3.1 32.81 1,058 — 3.1 32.81 $40.01 - $50.00 12 — 1.7 45.57 12 — 1.7 45.57 $50.01 - $60.00 127 — 2.4 51.70 127 — 2.4 51.70 1,222 $ — 3.0 34.80 1,222 $ — 3.0 34.80 |
Summary of information on options exercised | Year ended December 31, 2018 2017 2016 (in thousands) Cash received from options exercised $ — $ 431 $ 494 Intrinsic value of options exercised $ — $ 51 $ 1,165 |
Summary of non-vested restricted and performance shares activity | Weighted Average Number of Grant Date Shares Fair Value (in thousands) Balance - December 31, 2015 1,398 $ 31.97 Granted 1,166 17.59 Vested (349) 32.73 Forfeited (266) 27.31 Balance - December 31, 2016 1,949 23.85 Granted 674 29.22 Performance award adjustments (25) 20.95 Assumed from Ultratech 338 31.75 Vested (831) 27.67 Forfeited (225) 26.29 Balance - December 31, 2017 1,880 25.41 Granted 1,257 17.37 Performance award adjustments (5) 32.67 Vested (523) 26.39 Forfeited (391) 24.66 Balance - December 31, 2018 2,218 20.74 |
Summary of valuation assumptions for performance awards | Year ended December 31, 2018 Weighted average fair value $ 15.58 Dividend yield 0 % Expected volatility factor (1) 49 % Risk-free interest rate (2) 2.88 % Expected life (in years) (3) 3.0 (1) Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term. (2) The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant. (3) The expected life is the number of years the Company estimates that the awards will be outstanding prior to exercise. |
Summary of valuation assumptions for employee stock purchase plan | Year ended December 31, 2018 2017 2016 Weighted average fair value $ 4.94 $ 7.09 $ 4.45 Dividend yield 0 % 0 % 0 % Expected volatility factor (1) 62 % 36 % 43 % Risk-free interest rate (2) 1.81 % 0.99 % 0.35 % Expected life (in years) (3) 0.5 0.5 0.5 (1) Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term. (2) The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant. (3) The expected life is the number of years the Company estimates that the purchase rights will be outstanding prior to exercise. |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Income Taxes | |
Schedule of income (loss) from continuing operations before income taxes | Year ended December 31, 2018 2017 2016 (in thousands) Domestic $ (286,561) $ (101,573) $ (123,089) Foreign (147,273) 12,583 3,885 Total $ (433,834) $ (88,990) $ (119,204) |
Schedule of components of the expense (benefit) for income taxes | Year ended December 31, 2018 2017 2016 (in thousands) Current: Federal $ (1,682) $ — $ — Foreign 2,518 (2,246) 1,937 State and local 38 15 (111) Total current expense (benefit) for income taxes 874 (2,231) 1,826 Deferred: Federal 205 (35,912) 1,459 Foreign (27,932) 1,291 (589) State and local 107 (742) 127 Total deferred expense (benefit) for income taxes (27,620) (35,363) 997 Total expense (benefit) for income taxes $ (26,746) $ (37,594) $ 2,823 |
Schedule of reconciliation of the income tax expense computed using the Federal statutory rate to actual income tax provision | Year ended December 31, 2018 2017 2016 (in thousands) Income tax expense (benefit) at U.S. statutory rates $ (91,105) $ (31,147) $ (41,722) State taxes, net of U.S. federal impact (2,848) (2,523) (1,963) Effect of international operations 11,847 10,158 8,798 Research and development tax credit (2,230) 620 (801) Net change in valuation allowance 7,747 1,883 50,544 Change in accrual for unrecognized tax benefits 2,868 (4,772) (1,700) Subsidiary liquidation — — (12,435) Share-based compensation 1,848 99 2,133 Effect of 2017 Tax Act (1,690) (11,344) — Asset impairment 46,872 — — Other (55) (568) (31) Total expense (benefit) for income taxes $ (26,746) $ (37,594) $ 2,823 |
Schedule of deferred tax assets and liabilities | December 31, 2018 2017 (in thousands) Deferred tax assets: Inventory valuation $ 8,943 $ 8,007 Net operating losses 67,787 73,458 Credit carry forwards 52,592 34,966 Warranty and installation accruals 1,695 1,690 Share-based compensation 6,981 7,385 Other 2,182 1,832 Total deferred tax assets 140,180 127,338 Valuation allowance (114,955) (100,456) Net deferred tax assets 25,225 26,882 Deferred tax liabilities: Purchased intangible assets 15,401 45,807 Convertible Senior Notes 11,265 13,534 Depreciation 2,380 1,339 Total deferred tax liabilities 29,046 60,680 Net deferred taxes $ (3,821) $ (33,798) |
Schedule of reconciliation of beginning and ending amount of uncertain tax positions | December 31, 2018 2017 2016 (in thousands) Balance at beginning of year $ 8,269 $ 7,452 $ 9,152 Additions for tax positions related to current year 2,154 511 1,038 Additions for tax positions related to prior years 1,721 3 233 Reductions for tax positions related to prior years (934) (4,877) (2,826) Reductions due to the lapse of the statute of limitations (26) (122) (39) Settlements (47) (287) (106) Additions for business combination — 5,589 — Balance at end of year $ 11,137 $ 8,269 $ 7,452 |
Segment Reporting and Geograp_2
Segment Reporting and Geographic Information (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Segment Reporting and Geographic Information | |
Schedule of sales by end-market | For the year ended December 31, 2018 2017 2016 (in thousands) Sales by end-market Advanced Packaging, MEMS & RF Filters $ 90,775 $ 67,406 $ 67,484 LED Lighting, Display & Compound Semiconductor 249,974 248,615 145,701 Front-End Semiconductor 62,582 40,319 8,427 Scientific & Industrial 138,751 119,346 110,090 Total $ 542,082 $ 475,686 $ 331,702 |
Schedule of sales by geographic region | Net Sales to Unaffiliated Customers Long-lived Tangible Assets 2018 2017 2016 2018 2017 2016 (in thousands) United States $ 125,659 $ 93,433 $ 85,582 $ 78,503 $ 81,046 $ 60,012 China 194,032 106,674 84,604 81 64 219 EMEA (1) 89,102 72,979 84,181 205 231 93 Rest of World 133,289 202,600 77,335 1,495 3,717 322 Total $ 542,082 $ 475,686 $ 331,702 $ 80,284 $ 85,058 $ 60,646 (1) EMEA consists of Europe, the Middle East, and Africa |
Selected Quarterly Financial _2
Selected Quarterly Financial Information (unaudited) (Tables) | 12 Months Ended |
Dec. 31, 2018 | |
Selected Quarterly Financial Information (unaudited) | |
Schedule of unaudited quarterly financial data | Fiscal 2018 Fiscal 2017 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 (in thousands, except per share amounts) Net sales $ 158,574 $ 157,779 $ 126,757 $ 98,972 $ 94,499 $ 112,218 $ 129,308 $ 139,661 Gross profit 56,680 55,395 46,385 35,259 34,500 35,847 50,529 55,352 Net income (loss) (15,827) (237,634) (8,953) (144,674) 1,640 (20,817) (23,740) (8,479) Basic income (loss) per common share (0.34) (5.02) (0.19) (3.11) 0.04 (0.49) (0.51) (0.18) Diluted income (loss) per common share (0.34) (5.02) (0.19) (3.11) 0.04 (0.49) (0.51) (0.18) |
Significant Accounting Polici_4
Significant Accounting Policies - Description of Business (Details) | 12 Months Ended |
Dec. 31, 2018segment | |
Significant Accounting Policies | |
Number of Operating Segments | 1 |
Significant Accounting Polici_5
Significant Accounting Policies - Basis of Presentation (Details) | 12 Months Ended |
Dec. 31, 2018 | |
Significant Accounting Policies | |
Fiscal period duration (in days) | 91 days |
Significant Accounting Polici_6
Significant Accounting Policies - Revenue Recognition (Details) | 12 Months Ended |
Dec. 31, 2018 | |
Accounting Changes | |
Revenue, Practical Expedient, Incremental Cost of Obtaining Contract [true false] | true |
Adjustments for adoption of guidance | ASU 2014-09, Revenue from Contracts with Customers | |
Accounting Changes | |
Billing retention recognized at time of transfer of control (as a percent) | 10.00% |
Significant Accounting Polici_7
Significant Accounting Policies - Warranty Costs (Details) | 12 Months Ended |
Dec. 31, 2018 | |
Significant Accounting Policies | |
Warranty period | 1 year |
Significant Accounting Polici_8
Significant Accounting Policies - Advertising Expense (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Significant Accounting Policies | |||
Advertising expense | $ 0.9 | $ 0.9 | $ 0.8 |
Significant Accounting Polici_9
Significant Accounting Policies - Accounting for Share-Based Compensation (Details) $ in Millions | 12 Months Ended | ||
Dec. 31, 2018USD ($)item | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | |
Significant Accounting Policies | |||
Number of awards with which entity has elected to treat awards with only service conditions and with graded vesting | item | 1 | ||
Advertising expense | $ | $ 0.9 | $ 0.9 | $ 0.8 |
Significant Accounting Polic_10
Significant Accounting Policies - Concentration of Credit Risk (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Significant Accounting Policies | ||
Allowance for doubtful accounts receivable | $ 0.3 | $ 0.3 |
Maturity period of irrevocable letters of credit, minimum | 0 days | |
Maturity period of irrevocable letters of credit, maximum | 90 days |
Significant Accounting Polic_11
Significant Accounting Policies - Cash, Cash Equivalents, and Short-Term Investments (Details) - USD ($) $ in Millions | Dec. 31, 2018 | Dec. 31, 2017 |
Significant Accounting Policies | ||
Cash equivalents | $ 69.6 | $ 76.7 |
Cash and cash equivalents maintained outside the United States (as a percent) | 32.00% | 77.00% |
Significant Accounting Polic_12
Significant Accounting Policies - Goodwill and Indefinite-Lived Intangibles (Details) | 12 Months Ended |
Dec. 31, 2018 | |
Significant Accounting Policies | |
Number of trading days used in adjusted market capitalization calculation | 10 days |
Significant Accounting Polic_13
Significant Accounting Policies - Recently Adopted Accounting Standards - Balance Sheet (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 | Jan. 01, 2016 |
Accounting Changes | |||
Contract assets | $ 10,397 | $ 160 | |
Deferred cost of sales | 3,072 | 15,994 | |
Deferred income taxes | 1,869 | 3,047 | |
Accrued expenses and other current liabilities | 46,450 | 58,068 | |
Customer deposits and deferred revenue | 72,736 | 112,032 | |
Additional paid-in capital | 1,061,325 | 1,051,953 | |
Accumulated deficit | $ (619,983) | (212,870) | |
ASU 2014-09, Revenue from Contracts with Customers | Previously Reported | |||
Accounting Changes | |||
Deferred cost of sales | 16,060 | ||
Deferred income taxes | 2,953 | ||
Accrued expenses and other current liabilities | 60,339 | ||
Customer deposits and deferred revenue | 108,953 | ||
Additional paid-in capital | 1,053,079 | ||
Accumulated deficit | (213,376) | ||
ASU 2014-09, Revenue from Contracts with Customers | Adjustments for adoption of guidance | |||
Accounting Changes | |||
Contract assets | 160 | ||
Deferred cost of sales | (66) | ||
Deferred income taxes | 94 | ||
Accrued expenses and other current liabilities | (2,271) | ||
Customer deposits and deferred revenue | 3,079 | ||
Additional paid-in capital | (1,126) | ||
Accumulated deficit | $ 506 | $ 6,900 |
Significant Accounting Polic_14
Significant Accounting Policies - Recently Adopted Accounting Standards - Statement of Operations (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2018 | Sep. 30, 2018 | Jun. 30, 2018 | Mar. 31, 2018 | Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Accounting Changes | |||||||||||
Net sales | $ 98,972 | $ 126,757 | $ 157,779 | $ 158,574 | $ 139,661 | $ 129,308 | $ 112,218 | $ 94,499 | $ 542,082 | $ 475,686 | $ 331,702 |
Cost of sales | 348,363 | 299,458 | 198,604 | ||||||||
Income tax expense (benefit) | (26,746) | (37,594) | 2,823 | ||||||||
Net income (loss) | $ (144,674) | $ (8,953) | $ (237,634) | $ (15,827) | $ (8,479) | $ (23,740) | $ (20,817) | $ 1,640 | $ (407,088) | $ (51,396) | $ (122,027) |
Diluted earnings (loss) per share (in dollars per share) | $ (3.11) | $ (0.19) | $ (5.02) | $ (0.34) | $ (0.18) | $ (0.51) | $ (0.49) | $ 0.04 | $ (8.63) | $ (1.16) | $ (3.10) |
Previously Reported | ASU 2014-09, Revenue from Contracts with Customers | |||||||||||
Accounting Changes | |||||||||||
Net sales | $ 484,756 | $ 332,451 | |||||||||
Cost of sales | 300,438 | 199,593 | |||||||||
Income tax expense (benefit) | (36,107) | 2,766 | |||||||||
Net income (loss) | $ (44,793) | $ (122,210) | |||||||||
Diluted earnings (loss) per share (in dollars per share) | $ (1.01) | $ (3.11) | |||||||||
Adjustments for adoption of guidance | ASU 2014-09, Revenue from Contracts with Customers | |||||||||||
Accounting Changes | |||||||||||
Net sales | $ (9,070) | $ (749) | |||||||||
Cost of sales | (980) | (989) | |||||||||
Income tax expense (benefit) | (1,487) | 57 | |||||||||
Net income (loss) | $ (6,603) | $ 183 | |||||||||
Diluted earnings (loss) per share (in dollars per share) | $ (0.15) | $ 0.01 |
Significant Accounting Polic_15
Significant Accounting Policies - Recently Adopted Accounting Standards - ASU 2016-09 (Details) - USD ($) | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Jan. 01, 2016 | Dec. 31, 2015 |
Accounting Changes | |||||
Accumulated deficit | $ (619,983,000) | $ (212,870,000) | |||
Additional paid-in capital | 1,061,325,000 | 1,051,953,000 | |||
Total stockholders' equity | 437,775,000 | 840,093,000 | $ 601,704,000 | $ 714,615,000 | |
Deferred tax assets before valuation allowance | 140,180,000 | 127,338,000 | |||
Deferred tax assets valuation allowance | $ 114,955,000 | $ 100,456,000 | |||
ASU 2016-09 | Early Adoption of New Accounting Principle | |||||
Accounting Changes | |||||
Accumulated deficit | $ (1,300,000) | ||||
Additional paid-in capital | 1,300,000 | ||||
Total stockholders' equity | 0 | ||||
Deferred tax assets before valuation allowance | 2,400,000 | ||||
Deferred tax assets valuation allowance | $ 2,400,000 |
Significant Accounting Polic_16
Significant Accounting Policies - Recent Accounting Pronouncements (Details) - ASU 2016-02 $ in Millions | Jan. 01, 2019USD ($) |
Minimum | |
Accounting Changes | |
Operating lease liability | $ 12 |
Operating lease asset | 12 |
Maximum | |
Accounting Changes | |
Operating lease liability | 16 |
Operating lease asset | $ 16 |
Income (Loss) Per Common Share
Income (Loss) Per Common Share - Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2018 | Sep. 30, 2018 | Jun. 30, 2018 | Mar. 31, 2018 | Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Income (Loss) Per Share | |||||||||||
Net income (loss) | $ (144,674) | $ (8,953) | $ (237,634) | $ (15,827) | $ (8,479) | $ (23,740) | $ (20,817) | $ 1,640 | $ (407,088) | $ (51,396) | $ (122,027) |
Net income (loss) per common share: | |||||||||||
Basic (in dollars per share) | $ (3.11) | $ (0.19) | $ (5.02) | $ (0.34) | $ (0.18) | $ (0.51) | $ (0.49) | $ 0.04 | $ (8.63) | $ (1.16) | $ (3.10) |
Diluted (in dollars per share) | $ (3.11) | $ (0.19) | $ (5.02) | $ (0.34) | $ (0.18) | $ (0.51) | $ (0.49) | $ 0.04 | $ (8.63) | $ (1.16) | $ (3.10) |
Weighted average shares reconciliation | |||||||||||
Basic weighted average shares outstanding | 47,151 | 44,174 | 39,340 | ||||||||
Diluted weighted average shares outstanding | 47,151 | 44,174 | 39,340 |
Income (Loss) Per Common Shar_2
Income (Loss) Per Common Share - Shares Excluded from EPS (Details) - shares shares in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Unvested participating shares | |||
Basic income (loss) per share | |||
Unvested participating shares excluded from basic weighted average shares outstanding since the securityholders are not obligated to fund losses | 20 | 72 | 312 |
Common stock equivalents | |||
Diluted income (loss) per share | |||
Common share equivalents excluded from the diluted weighted average shares outstanding since Veeco incurred a net loss and their effect would be antidilutive | 28 | 239 | 107 |
Non-participating shares | |||
Diluted income (loss) per share | |||
Shares excluded from the diluted calculation as their effect would be antidilutive | 2,474 | 1,744 | 1,896 |
Convertible Notes | |||
Diluted income (loss) per share | |||
Shares excluded from the diluted calculation as their effect would be antidilutive | 8,618 | 8,618 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - Measured at fair value on a recurring basis - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Cash equivalents | ||
Total Cash equivalents | $ 69,561 | $ 76,739 |
Short-term investments | ||
Total Short-term investments | 48,189 | 47,780 |
Certificate of deposits and time deposits | ||
Cash equivalents | ||
Total Cash equivalents | 65,571 | 64,249 |
U.S. treasuries | ||
Cash equivalents | ||
Total Cash equivalents | 3,990 | 12,490 |
Short-term investments | ||
Total Short-term investments | 37,184 | 33,895 |
Corporate debt | ||
Short-term investments | ||
Total Short-term investments | 8,516 | 10,886 |
Commercial paper | ||
Short-term investments | ||
Total Short-term investments | 2,489 | 2,999 |
Level 1 | ||
Cash equivalents | ||
Total Cash equivalents | 69,561 | 76,739 |
Short-term investments | ||
Total Short-term investments | 37,184 | 33,895 |
Level 1 | Certificate of deposits and time deposits | ||
Cash equivalents | ||
Total Cash equivalents | 65,571 | 64,249 |
Level 1 | U.S. treasuries | ||
Cash equivalents | ||
Total Cash equivalents | 3,990 | 12,490 |
Short-term investments | ||
Total Short-term investments | 37,184 | 33,895 |
Level 2 | ||
Short-term investments | ||
Total Short-term investments | 11,005 | 13,885 |
Level 2 | Corporate debt | ||
Short-term investments | ||
Total Short-term investments | 8,516 | 10,886 |
Level 2 | Commercial paper | ||
Short-term investments | ||
Total Short-term investments | $ 2,489 | $ 2,999 |
Investments - Available-For-Sal
Investments - Available-For-Sale Securities (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Total available-for-sale securities | ||
Amortized Cost | $ 48,205 | $ 47,807 |
Gross Unrealized Losses | (16) | (27) |
Estimated Fair Value | 48,189 | 47,780 |
Available-for-sale securities in a loss position | ||
Estimated Fair Value | 45,700 | 44,781 |
Gross Unrealized Losses | (16) | (27) |
Short-term investments in a continuous loss position | ||
Investments that had been in a continuous loss position for more than 12 months | 0 | 0 |
U.S. treasuries | ||
Total available-for-sale securities | ||
Amortized Cost | 37,191 | 33,914 |
Gross Unrealized Losses | (7) | (19) |
Estimated Fair Value | 37,184 | 33,895 |
Available-for-sale securities in a loss position | ||
Estimated Fair Value | 37,184 | 33,895 |
Gross Unrealized Losses | (7) | (19) |
Corporate debt | ||
Total available-for-sale securities | ||
Amortized Cost | 8,525 | 10,894 |
Gross Unrealized Losses | (9) | (8) |
Estimated Fair Value | 8,516 | 10,886 |
Available-for-sale securities in a loss position | ||
Estimated Fair Value | 8,516 | 10,886 |
Gross Unrealized Losses | (9) | (8) |
Commercial paper | ||
Total available-for-sale securities | ||
Amortized Cost | 2,489 | 2,999 |
Estimated Fair Value | $ 2,489 | $ 2,999 |
Investments - Other Investment
Investments - Other Investment (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Other Investment | |||
Impairment charges for investments | $ 0 | $ 0 | $ 0 |
Kateeva | |||
Other Investment | |||
Carrying amount | $ 21 | $ 21 | |
Kateeva | Maximum | |||
Other Investment | |||
Percentage ownership of cost method investee | 20.00% | ||
Separate non-marketable investment | |||
Other Investment | |||
Amount of investment made | $ 3.5 | ||
Separate non-marketable investment | Maximum | |||
Other Investment | |||
Percentage ownership of cost method investee | 20.00% |
Business Combinations - Ultrate
Business Combinations - Ultratech (Details) - Ultratech $ / shares in Units, $ in Thousands | May 26, 2017USD ($)$ / sharesshares |
Business Combinations | |
Cash received by acquiree (in dollars per share) | $ / shares | $ 21.75 |
Number of shares received by acquiree | shares | 0.2675 |
Acquisition date fair value, net of cash acquired | $ | $ 633,361 |
Business Combinations - Conside
Business Combinations - Consideration (Details) - Ultratech - USD ($) $ in Thousands, shares in Millions | May 26, 2017 | Dec. 31, 2017 |
Fair value of the consideration transferred | ||
Cash consideration, net of cash acquired | $ 404,490 | |
Cash acquired | 229,400 | |
Equity consideration (7.2 million shares issued) | $ 228,643 | |
Shares issued (in shares) | 7.2 | |
Replacement equity awards attributable to pre-acquisition service | $ 228 | |
Acquisition date fair value | $ 633,361 | |
Accrued expenses and other current liabilities | ||
Fair value of the consideration transferred | ||
Cash merger consideration | $ 2,700 |
Business Combinations- Fair Val
Business Combinations- Fair Value (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 | May 26, 2017 | Dec. 31, 2016 |
Summary of estimated fair values of the assets acquired and liabilities assumed | ||||
Goodwill | $ 184,302 | $ 307,131 | $ 114,908 | |
Ultratech | ||||
Summary of estimated fair values of the assets acquired and liabilities assumed | ||||
Short-term investments | $ 47,161 | |||
Account receivable | 45,465 | |||
Inventories | 59,100 | |||
Deferred cost of sales | 242 | |||
Prepaid expense and other current assets | 7,217 | |||
Property, plant, and equipment | 18,152 | |||
Intangible assets | 346,940 | |||
Other assets | 6,442 | |||
Total identifiable assets acquired | 530,719 | |||
Accounts payable | 24,291 | |||
Accrued expenses and other current liabilities | 16,356 | |||
Customer deposits and deferred revenue | 4,834 | |||
Deferred income taxes | 32,478 | |||
Other liabilities | 11,622 | |||
Total liabilities assumed | 89,581 | |||
Net identifiable assets acquired | 441,138 | |||
Goodwill | 192,223 | |||
Net assets acquired | 633,361 | |||
Gross contractual value of accounts receivable | $ 46,000 |
Business Combinations - Intangi
Business Combinations - Intangible Assets (Details) - Ultratech $ in Thousands | May 26, 2017USD ($) |
Intangible assets acquired and the estimated weighted-average useful life | |
Intangible assets acquired, amount | $ 346,940 |
In-process R&D | |
Intangible assets acquired and the estimated weighted-average useful life | |
Intangible assets acquired, amount | 43,340 |
Technology | |
Intangible assets acquired and the estimated weighted-average useful life | |
Intangible assets acquired, amount | $ 158,390 |
Useful life | 9 years |
Customer relationships | |
Intangible assets acquired and the estimated weighted-average useful life | |
Intangible assets acquired, amount | $ 116,710 |
Useful life | 12 years |
Backlog | |
Intangible assets acquired and the estimated weighted-average useful life | |
Intangible assets acquired, amount | $ 3,080 |
Useful life | 6 months |
Trademarks and tradenames | |
Intangible assets acquired and the estimated weighted-average useful life | |
Intangible assets acquired, amount | $ 25,420 |
Useful life | 7 years |
Business Combinations - IPRD an
Business Combinations - IPRD and other (Details) - USD ($) $ in Thousands | May 26, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 |
Business Combinations | ||||
Acquisition related costs | $ 2,959 | $ 17,786 | ||
Non-cash charges related to share based compensation | 16,074 | 24,396 | $ 15,741 | |
Amortization of intangible assets | 32,351 | 35,475 | 19,219 | |
Restructuring Charges. | 8,556 | 11,851 | $ 5,640 | |
Ultratech | ||||
Business Combinations | ||||
Intangible assets acquired, amount | $ 346,940 | |||
Portion of IPR&D related to lithography technologies (as a percent) | 50.00% | |||
Portion of IPR&D related to laser annealing technologies (as a percent) | 33.00% | |||
Acquisition related costs | $ 3,000 | 17,800 | ||
Non-cash charges related to share based compensation | 4,200 | |||
Net sales | 65,280 | |||
Loss before income taxes | (62,284) | |||
Inventory fair value step-up related to purchase accounting | 9,600 | |||
Amortization of intangible assets | 23,900 | |||
Restructuring Charges. | $ 3,300 | |||
In-process R&D | Ultratech | ||||
Business Combinations | ||||
Intangible assets acquired, amount | $ 43,340 |
Business Combinations - ProForm
Business Combinations - ProForma (Details) - Ultratech - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Pro forma consolidated statement of operations | ||
Net sales | $ 546,428 | $ 525,752 |
Loss before income taxes | $ (90) | $ (217,783) |
Diluted earnings per share (in dollars per share) | $ (1.38) | $ (4.67) |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets - Goodwill (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Goodwill | ||
Gross carrying amount, beginning balance | $ 430,331 | $ 238,108 |
Accumulated impairment, beginning balance | 123,200 | 123,200 |
Net amount, beginning balance | 307,131 | 114,908 |
Acquisition | 192,223 | |
Impairment | 122,829 | |
Gross carrying amount, ending balance | 430,331 | 430,331 |
Accumulated impairment, ending balance | 246,029 | 123,200 |
Net amount, ending balance | $ 184,302 | $ 307,131 |
Number of trading days used in adjusted market capitalization calculation | 10 days |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Jun. 30, 2018 | Dec. 31, 2018 | Dec. 31, 2016 | Dec. 31, 2017 | |
Intangible assets | ||||
Weighted Average Remaining Amortization Period | 7 years 3 months 18 days | |||
Net Amount, Definite-lived intangible assets | $ 81,969 | |||
Total Gross Intangible Assets | 550,119 | $ 550,119 | ||
Accumulated Amortization and Impairment | 464,970 | 180,276 | ||
Total Net Intangible Assets | 85,149 | 369,843 | ||
Impairment charges, Definite-lived intangible assets | $ 216,400 | |||
In-process R&D | ||||
Intangible assets | ||||
Gross Carrying Amount, Indefinite-lived intangible assets | 13,710 | 43,340 | ||
Accumulated Amortization and Impairment, Indefinite-lived intangible assets | 10,530 | |||
Net Amount, Indefinite-lived intangible assets | $ 3,180 | 43,340 | ||
Impairment charges, Indefinite-lived intangible assets | $ 35,900 | |||
Technology | ||||
Intangible assets | ||||
Weighted Average Remaining Amortization Period | 6 years 4 months 24 days | |||
Gross Carrying Amount, Definite-lived intangible assets | $ 337,218 | 307,588 | ||
Accumulated Amortization and Impairment, Definite-lived intangible assets | 290,808 | 133,121 | ||
Net Amount, Definite-lived intangible assets | $ 46,410 | 174,467 | ||
Impairment charges, Definite-lived intangible assets | $ 54,300 | |||
Customer relationships | ||||
Intangible assets | ||||
Weighted Average Remaining Amortization Period | 10 years 2 months 12 days | |||
Gross Carrying Amount, Definite-lived intangible assets | $ 164,595 | 164,595 | ||
Accumulated Amortization and Impairment, Definite-lived intangible assets | 136,126 | 39,336 | ||
Net Amount, Definite-lived intangible assets | $ 28,469 | 125,259 | ||
Trademarks and tradenames | ||||
Intangible assets | ||||
Weighted Average Remaining Amortization Period | 5 years 4 months 24 days | |||
Gross Carrying Amount, Definite-lived intangible assets | $ 30,910 | 30,910 | ||
Accumulated Amortization and Impairment, Definite-lived intangible assets | 23,899 | 4,321 | ||
Net Amount, Definite-lived intangible assets | $ 7,011 | 26,589 | ||
Other Intangible Assets | ||||
Intangible assets | ||||
Weighted Average Remaining Amortization Period | 1 year 3 months 18 days | |||
Gross Carrying Amount, Definite-lived intangible assets | $ 3,686 | 3,686 | ||
Accumulated Amortization and Impairment, Definite-lived intangible assets | 3,607 | 3,498 | ||
Net Amount, Definite-lived intangible assets | $ 79 | $ 188 |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets - Amortization (Details) $ in Thousands | Dec. 31, 2018USD ($) |
Estimated aggregate amortization expense | |
2019 | $ 16,820 |
2020 | 15,894 |
2021 | 12,772 |
2022 | 10,438 |
2023 | 8,675 |
Thereafter | 17,370 |
Net Amount, Definite-lived intangible assets | $ 81,969 |
Inventories (Details)
Inventories (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Inventories | ||
Materials | $ 90,816 | $ 59,919 |
Work-in-process | 42,354 | 37,222 |
Finished goods | 23,141 | 23,125 |
Total | $ 156,311 | $ 120,266 |
Property, Plant, and Equipmen_3
Property, Plant, and Equipment and Assets Held for Sale - Property and Equipment (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Property, plant, and equipment | |||
Gross property, plant and equipment | $ 204,211 | $ 197,020 | |
Less: accumulated depreciation and amortization | 123,927 | 111,962 | |
Net property, plant, and equipment | 80,284 | 85,058 | $ 60,646 |
Depreciation expense | 17,600 | 14,600 | 13,400 |
Property, plant and equipment, impairment charge | $ 3,300 | ||
Land | |||
Property, plant, and equipment | |||
Gross property, plant and equipment | 5,669 | 5,669 | |
Building and improvements | |||
Property, plant, and equipment | |||
Gross property, plant and equipment | $ 61,124 | 54,449 | |
Building and improvements | Minimum | |||
Property, plant, and equipment | |||
Average Useful Life | 10 years | ||
Building and improvements | Maximum | |||
Property, plant, and equipment | |||
Average Useful Life | 40 years | ||
Machinery and equipment | |||
Property, plant, and equipment | |||
Gross property, plant and equipment | $ 128,385 | 126,829 | |
Machinery and equipment | Minimum | |||
Property, plant, and equipment | |||
Average Useful Life | 3 years | ||
Machinery and equipment | Maximum | |||
Property, plant, and equipment | |||
Average Useful Life | 10 years | ||
Leaseholds improvements | |||
Property, plant, and equipment | |||
Gross property, plant and equipment | $ 9,033 | $ 10,073 | |
Leaseholds improvements | Minimum | |||
Property, plant, and equipment | |||
Average Useful Life | 3 years | ||
Leaseholds improvements | Maximum | |||
Property, plant, and equipment | |||
Average Useful Life | 7 years |
Property, Plant, and Equipmen_4
Property, Plant, and Equipment and Assets Held For Sale - Assets Held For Sale (Details) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($)building | |
Assets held for sale | |||
Asset impairment charges | $ 375,172 | $ 1,139 | $ 69,520 |
Assets held for sale | $ 0 | 0 | |
South Korea | |||
Assets held for sale | |||
Number of facilities listed for sale | building | 2 | ||
Asset impairment charges | $ 4,500 | ||
St. Paul, Minnesota | |||
Assets held for sale | |||
Asset impairment charges | $ 700 | 1,200 | |
Lab equipment | |||
Assets held for sale | |||
Non-cash impairment charges | $ 6,200 |
Accrued Expenses and Other Li_3
Accrued Expenses and Other Liabilities - Components (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Accrued expenses and other current liabilities | ||
Payroll and related benefits | $ 20,486 | $ 32,996 |
Warranty | 7,852 | 6,532 |
Interest | 4,321 | 4,430 |
Professional fees | 2,897 | 3,942 |
Merger consideration payable | 2,662 | |
Sales, use, and other taxes | 2,670 | 2,144 |
Restructuring liability | 2,213 | 1,520 |
Other | 6,011 | 3,842 |
Total | $ 46,450 | $ 58,068 |
Accrued Expenses and Other Li_4
Accrued Expenses and Other Liabilities - Customer deposits and deferred revenue (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Customer deposits and deferred revenue | ||
Customer deposits and deferred revenue | $ 28,300 | $ 41,500 |
Changes in deferred revenue | ||
Beginning balance | 70,536 | |
Deferral of revenue | 10,251 | |
Recognition of previously deferred revenue | (36,372) | |
Ending balance | $ 44,415 |
Accrued Expenses and Other Li_5
Accrued Expenses and Other Liabilities - Performance Obligation Amount (Details) $ in Millions | Dec. 31, 2018USD ($) |
Accrued Expenses and Other Liabilities | |
Remaining performance obligations | $ 74 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01 | |
Performance obligations | |
Percentage of remaining performance obligation expected to be recognized | 67.00% |
Accrued Expenses and Other Li_6
Accrued Expenses and Other Liabilities - Performance Obligation Timing (Details) | 12 Months Ended |
Dec. 31, 2018 | |
Accrued Expenses and Other Liabilities | |
Revenue, Practical Expedient, Remaining Performance Obligation | true |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-01-01 | |
Performance obligations | |
Remaining performance obligations, expected timing of satisfaction | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01 | |
Performance obligations | |
Remaining performance obligations, expected timing of satisfaction | 3 years |
Accrued Expenses and Other Li_7
Accrued Expenses and Other Liabilities - Other liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Other liabilities | ||
Income taxes payable | $ 1,256 | $ 3,846 |
Other Assets | ||
Other liabilities | ||
Deferred compensation plan assets | 3,200 | 3,400 |
Other Liabilities | ||
Other liabilities | ||
Deferred compensation plan liabilities | 3,500 | 4,700 |
Asset retirement obligations | 3,200 | 3,300 |
Medical and dental benefits | 2,200 | $ 2,200 |
Income taxes payable | $ 1,000 |
Restructuring Charges - Informa
Restructuring Charges - Information (Details) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Sep. 30, 2018USD ($)employee | Jun. 30, 2018employee | Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | |
Restructuring Accruals | |||||
Restructuring charges | $ 8,556 | $ 11,851 | $ 5,640 | ||
Non-cash charges related to share based compensation | 16,074 | 24,396 | $ 15,741 | ||
Reduce excess capacity | |||||
Restructuring Accruals | |||||
Number of employees terminated | employee | 40 | ||||
Reduce costs | |||||
Restructuring Accruals | |||||
Number of employees terminated | employee | 35 | ||||
Restructuring | |||||
Restructuring Accruals | |||||
Non-cash charges related to share based compensation | 1,200 | $ 1,900 | |||
Personnel severance and related costs | Reduce excess capacity | |||||
Restructuring Accruals | |||||
Restructuring charges | $ 2,800 | ||||
Personnel severance and related costs | Reduce costs | |||||
Restructuring Accruals | |||||
Restructuring charges | $ 1,200 |
Restructuring Charges - Rollfor
Restructuring Charges - Rollforward (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Restructuring accruals roll forward | |||
Balance at the beginning of the period | $ 1,520 | $ 1,796 | $ 824 |
Provision | 7,395 | 9,971 | 5,642 |
Changes in estimate | (2) | ||
Payments | (6,702) | (10,247) | (4,668) |
Balance at the end of the period | 2,213 | 1,520 | 1,796 |
Personnel severance and related costs | |||
Restructuring accruals roll forward | |||
Balance at the beginning of the period | 1,520 | 1,796 | 824 |
Provision | 4,681 | 4,714 | 4,544 |
Changes in estimate | (2) | ||
Payments | (4,058) | (4,990) | (3,570) |
Balance at the end of the period | 2,143 | 1,520 | 1,796 |
Facility Closing Costs | |||
Restructuring accruals roll forward | |||
Provision | 2,714 | 5,257 | 1,098 |
Payments | (2,644) | $ (5,257) | $ (1,098) |
Balance at the end of the period | $ 70 |
Commitments and Contingencies -
Commitments and Contingencies - Warranty (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Warranty | |||
Warranty period of products purchased | 1 year | ||
Balance, beginning of the year | $ 6,532 | $ 4,217 | $ 8,159 |
Warranties issued | 6,737 | 5,817 | 3,916 |
Addition from Ultratech acquisition | 1,889 | ||
Consumption of reserves | (6,573) | (6,330) | (6,433) |
Changes in estimate | 1,156 | 939 | (1,425) |
Balance, end of the year | $ 7,852 | $ 6,532 | $ 4,217 |
Commitments and Contingencies_2
Commitments and Contingencies - Minimum Lease Commitments (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Minimum lease payments under non-cancelable leases | |||
Lease expense | $ 6,300 | $ 5,300 | $ 2,500 |
Property and equipment under operating leases | |||
Minimum lease payments under non-cancelable leases | |||
2019 | 5,143 | ||
2020 | 5,056 | ||
2021 | 2,432 | ||
2022 | 1,812 | ||
2023 | 1,066 | ||
Thereafter | 548 | ||
Total | $ 16,057 |
Commitments and Contingencies_3
Commitments and Contingencies - Legal Proceedings (Detail) | Aug. 08, 2018case |
Commitments and Contingencies | |
Number of purported class action complaints filed | 2 |
Commitments and Contingencies_4
Commitments and Contingencies - Concentration of Credit Risk (Details) - customer | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Ten largest customers | |||
Concentration of Credit Risk | |||
Number of customers | 10 | ||
Accounts Receivable | Credit Concentration Risk | Ten largest customers | |||
Concentration of Credit Risk | |||
Concentration Risk (as a percent) | 61.00% | 67.00% | |
Accounts Receivable | Credit Concentration Risk | Customer A | |||
Concentration of Credit Risk | |||
Concentration Risk (as a percent) | 24.00% | ||
Accounts Receivable | Credit Concentration Risk | Customer B | |||
Concentration of Credit Risk | |||
Concentration Risk (as a percent) | 22.00% | ||
Net Sales | Credit Concentration Risk | Customer A | |||
Concentration of Credit Risk | |||
Concentration Risk (as a percent) | 21.00% | 14.00% | |
Net Sales | Credit Concentration Risk | Customer C | |||
Concentration of Credit Risk | |||
Concentration Risk (as a percent) | 12.00% |
Commitments and Contingencies_5
Commitments and Contingencies - Receivables (Details) | 12 Months Ended |
Dec. 31, 2018 | |
Minimum | |
Concentration of Credit Risk | |
Credit period for accounts receivable | 30 days |
Maximum | |
Concentration of Credit Risk | |
Credit period for accounts receivable | 90 days |
Commitments and Contingencies_6
Commitments and Contingencies - Receivable Purchase Agreement (Details) - USD ($) $ in Millions | 1 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2018 | |
Commitments and Contingencies | ||
Trade receivables from customers without recourse to be sold, maximum amount | $ 23 | |
Receivable Purchase Agreement, term | 1 year | |
Trade receivables, sold | $ 15 | $ 0 |
Trade receivable, available for additional sales | $ 8 |
Commitments and Contingencies_7
Commitments and Contingencies - Suppliers (Details) - USD ($) $ in Millions | Dec. 31, 2018 | Dec. 31, 2017 |
Purchase Commitments | ||
Deposits with suppliers | $ 12.8 | $ 7.6 |
Commitments and Contingencies_8
Commitments and Contingencies - Purchase Commitments and Bank Guarantees (Details) $ in Millions | Dec. 31, 2018USD ($) |
Purchase commitments | |
Purchase commitments due within one year | $ 91.5 |
Bank guarantees | |
Bank guarantees and letters of credit outstanding | 6.8 |
Unused bank guarantees and letters of credit | $ 58.9 |
Debt - Convertible Senior Notes
Debt - Convertible Senior Notes (Details) | Jan. 10, 2017USD ($)D$ / shares | Dec. 31, 2017USD ($) | Dec. 31, 2018USD ($) |
Debt | |||
Proceeds from long-term debt borrowings | $ 335,752,000 | ||
Convertible Notes | |||
Debt | |||
Principal amount | $ 345,000,000 | 345,000,000 | $ 345,000,000 |
Interest rate (as a percent) | 2.70% | ||
Proceeds from long-term debt borrowings | $ 335,800,000 | ||
Conversion rate | 0.249800 | ||
Conversion price (in dollars per share) | $ / shares | $ 40.03 | ||
Multiples of principal holders may convert | $ 1,000 | ||
Consecutive trading days | D | 30 | ||
Stock price trigger (as a percent) | 130.00% | ||
Trading days | 5 | ||
Number of consecutive business days | 5 days | ||
Maximum percentage of common stock conversion | 98.00% | ||
Measurement input | 7 | ||
Long-term Debt, Measurement Input [Extensible List] | us-gaap:MeasurementInputDiscountRateMember | ||
Debt discount | $ 72,500,000 | $ 63,022,000 | $ 52,336,000 |
Transaction costs | 9,200,000 | ||
Transaction costs allocated to the equity component | $ 1,900,000 | ||
Convertible Notes | Minimum | |||
Debt | |||
Trading days | D | 20 |
Debt - Carrying Value - Convert
Debt - Carrying Value - Convertible Senior Notes (Details) - Convertible Notes - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 | Jan. 10, 2017 |
Debt | |||
Principal amount | $ 345,000 | $ 345,000 | $ 345,000 |
Unamortized debt discount | (52,336) | (63,022) | $ (72,500) |
Unamortized transaction costs | (5,272) | (6,348) | |
Net carrying value | $ 287,392 | $ 275,630 |
Debt - Interest Expense - Conve
Debt - Interest Expense - Convertible Senior Notes (Details) - Convertible Notes - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Cash Interest Expense | ||
Coupon interest expense | $ 9,315 | $ 8,901 |
Non-Cash Interest Expense | ||
Amortization of debt discount | 10,686 | 9,490 |
Amortization of transaction costs | 1,076 | 956 |
Total Interest Expense | 21,077 | $ 19,347 |
Estimated fair value | $ 255,300 | |
Convertible Debt, Fair Value by Fair Value Hierarchy Level [Extensible List] | Fair Value Inputs Level2 [Member] |
Derivative Financial Instrume_3
Derivative Financial Instruments (Details) - Not designated as hedges - Foreign currency exchange forwards - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Derivative Financial Instruments | |||
Notional Amounts | $ 622 | ||
Gains (losses) | $ 327 | (6) | $ 219 |
Weighted average notional amount | $ 2,869 | $ 314 | $ 7,175 |
Stockholders' Equity - Changes
Stockholders' Equity - Changes in AOCI (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Changes in the balances of each component of AOCI | |||
Balance at the beginning of the period | $ 840,093 | $ 601,704 | $ 714,615 |
Total other comprehensive income (loss), net of tax | 8 | 35 | 429 |
Balance at the end of the period | 437,775 | 840,093 | 601,704 |
Accumulated Other Comprehensive Income | |||
Changes in the balances of each component of AOCI | |||
Balance at the beginning of the period | 1,812 | 1,777 | 1,348 |
Other comprehensive income (loss) before reclassifications | (25) | ||
Amounts reclassified from AOCI | 454 | ||
Total other comprehensive income (loss), net of tax | 8 | 35 | 429 |
Balance at the end of the period | 1,820 | 1,812 | 1,777 |
Foreign Currency Translation | |||
Changes in the balances of each component of AOCI | |||
Balance at the beginning of the period | 1,839 | 1,797 | 2,246 |
Other comprehensive income (loss) before reclassifications | (19) | ||
Amounts reclassified from AOCI | (430) | ||
Total other comprehensive income (loss), net of tax | (3) | 42 | (449) |
Balance at the end of the period | 1,836 | 1,839 | 1,797 |
Minimum pension liability | |||
Changes in the balances of each component of AOCI | |||
Balance at the beginning of the period | (866) | ||
Amounts reclassified from AOCI | 866 | ||
Total other comprehensive income (loss), net of tax | 866 | ||
Unrealized Gains (Losses) on Available for Sale Securities | |||
Changes in the balances of each component of AOCI | |||
Balance at the beginning of the period | (27) | (20) | (32) |
Other comprehensive income (loss) before reclassifications | (6) | ||
Amounts reclassified from AOCI | 18 | ||
Total other comprehensive income (loss), net of tax | 11 | (7) | 12 |
Balance at the end of the period | $ (16) | $ (27) | $ (20) |
Stockholders' Equity - Reclassi
Stockholders' Equity - Reclassification out of AOCI (Details) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($)subsidiary | |
Reclassification out of AOCI | |||
Other income (expense), net | $ (368) | $ 392 | $ (223) |
Income tax expense (benefit) | $ (26,746) | $ (37,594) | 2,823 |
Minimum pension liability | Reclassification out of AOCI | |||
Reclassification out of AOCI | |||
Other income (expense), net | (900) | ||
Income tax expense (benefit) | (400) | ||
Foreign Currency Translation | Reclassification out of AOCI | |||
Reclassification out of AOCI | |||
Other income (expense), net | $ 400 | ||
South Korea | |||
Reclassification out of AOCI | |||
Number of subsidiaries liquidated | subsidiary | 1 |
Stockholders' Equity - Preferre
Stockholders' Equity - Preferred Stock (Details) - $ / shares | Dec. 31, 2018 | Dec. 31, 2017 |
Equity | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares issued | 0 | 0 |
Stockholders' Equity - Treasury
Stockholders' Equity - Treasury Stock (Details) - USD ($) $ in Thousands | 12 Months Ended | 13 Months Ended | |||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2018 | Dec. 11, 2017 | |
Treasury Stock | |||||
Authorized amount of common stock repurchase (in dollars) | $ 100,000 | ||||
Purchase of common stock | $ 11,309 | $ 3,018 | $ 13,035 | $ 14,300 |
Stock Plans - 2010 Plan (Detail
Stock Plans - 2010 Plan (Details) - shares | 12 Months Ended | ||||
Dec. 31, 2018 | Dec. 31, 2013 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Share-based compensation | |||||
Number of options outstanding (in shares) | 1,222,000 | 1,394,000 | 1,576,000 | 2,064,000 | |
Inducement Plan | |||||
Share-based compensation | |||||
Common stock available for grant (in shares) | 0 | ||||
2010 Stock Incentive Plan | |||||
Share-based compensation | |||||
Number of shares authorized | 10,600,000 | ||||
Stock options | Inducement Plan | |||||
Share-based compensation | |||||
Awards granted (in shares) | 124,500 | ||||
Vesting period | 3 years | ||||
Expiration term | 10 years | ||||
Number of options outstanding (in shares) | 2,000 | ||||
Stock options | 2010 Stock Incentive Plan | |||||
Share-based compensation | |||||
Vesting period | 3 years | ||||
Number of options outstanding (in shares) | 1,200,000 | ||||
Stock options | 2010 Stock Incentive Plan | Minimum | |||||
Share-based compensation | |||||
Expiration term | 7 years | ||||
Stock options | 2010 Stock Incentive Plan | Maximum | |||||
Share-based compensation | |||||
Expiration term | 10 years | ||||
Restricted stock awards and restricted stock units | 2010 Stock Incentive Plan | Minimum | |||||
Share-based compensation | |||||
Vesting period | 1 year | ||||
Restricted stock awards and restricted stock units | 2010 Stock Incentive Plan | Maximum | |||||
Share-based compensation | |||||
Vesting period | 5 years | ||||
Restricted stock units | Inducement Plan | |||||
Share-based compensation | |||||
Awards granted (in shares) | 87,000 | ||||
Number of awards outstanding (in shares) | 0 | ||||
Restricted stock units | Inducement Plan | Minimum | |||||
Share-based compensation | |||||
Vesting period | 2 years | ||||
Restricted stock units | Inducement Plan | Maximum | |||||
Share-based compensation | |||||
Vesting period | 4 years | ||||
RSUs and PSUs | 2010 Stock Incentive Plan | |||||
Share-based compensation | |||||
Number of awards outstanding (in shares) | 900,000 |
Stock Plans - ESPP (Details)
Stock Plans - ESPP (Details) - ESPP | 12 Months Ended |
Dec. 31, 2016shares | |
Share-based compensation | |
Number of shares authorized | 750,000 |
Share price (as a percent) | 85.00% |
Offer period | 6 months |
Stock Plans - Ultratech Plan (D
Stock Plans - Ultratech Plan (Details) - Ultratech Plan - shares | May 17, 2017 | Dec. 31, 2017 | Dec. 31, 2018 |
Share-based compensation | |||
Shares that may be granted in future under Plan | 0 | ||
Restricted stock units | |||
Share-based compensation | |||
Awards converted (in shares) | 338,144 | ||
Vesting period | 50 months | ||
Number of awards outstanding (in shares) | 30,200 |
Stock Plans - Shares Reserved f
Stock Plans - Shares Reserved for Future Issuance (Details) shares in Millions | Dec. 31, 2018shares |
2010 Stock Incentive Plan | |
Shares reserved for future issuance | |
Total shares reserved | 4.5 |
ESPP | |
Shares reserved for future issuance | |
Total shares reserved | 0.2 |
Stock Plans - Recognized Share-
Stock Plans - Recognized Share-based Compensation (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Recognized share-based compensation | |||
Total | $ 16,074 | $ 24,396 | $ 15,713 |
Cost of sales | |||
Recognized share-based compensation | |||
Total | 1,885 | 2,505 | 1,956 |
Research and development | |||
Recognized share-based compensation | |||
Total | 3,611 | 2,957 | 3,324 |
Selling, general and administrative | |||
Recognized share-based compensation | |||
Total | 9,417 | 12,851 | $ 10,433 |
Restructuring | |||
Recognized share-based compensation | |||
Total | $ 1,161 | 1,880 | |
Acquisition costs | |||
Recognized share-based compensation | |||
Total | $ 4,203 |
Stock Plans - Unrecognized Shar
Stock Plans - Unrecognized Share-based Compensation Costs (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2018USD ($) | |
Unrecognized share-based compensation costs | |
Unrecognized Share-Based Compensation Costs | $ 29,485 |
Weighted Average Period Expected to be Recognized | 2 years 6 months |
Restricted stock units | |
Unrecognized share-based compensation costs | |
Unrecognized Share-Based Compensation Costs | $ 2,466 |
Weighted Average Period Expected to be Recognized | 2 years 4 months 24 days |
Restricted stock awards | |
Unrecognized share-based compensation costs | |
Unrecognized Share-Based Compensation Costs | $ 19,663 |
Weighted Average Period Expected to be Recognized | 2 years 7 months 6 days |
Performance share units | |
Unrecognized share-based compensation costs | |
Unrecognized Share-Based Compensation Costs | $ 7,356 |
Weighted Average Period Expected to be Recognized | 2 years 4 months 24 days |
Stock Plans - Stock Option Awar
Stock Plans - Stock Option Awards (Details) shares in Thousands | 12 Months Ended |
Dec. 31, 2018$ / sharesshares | |
Vested | |
Number of Shares | shares | 1,222 |
Weighted Average Exercise Price | $ 34.80 |
Weighted Average Remaining Contractual Life | 3 years |
Total | |
Number of Shares | shares | 1,222 |
Weighted Average Exercise Price | $ 34.80 |
Weighted Average Remaining Contractual Life | 3 years |
Closing price | $ 7.41 |
Stock Plans - Stock Option Acti
Stock Plans - Stock Option Activity (Details) - $ / shares shares in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Number of Shares | |||
Outstanding at the beginning of the period (in shares) | 1,394 | 1,576 | 2,064 |
Exercised (in shares) | (18) | (194) | |
Expired or forfeited (in shares) | (172) | (164) | (294) |
Outstanding at the end of the period (in shares) | 1,222 | 1,394 | 1,576 |
Weighted Average Exercise Price | |||
Outstanding at the beginning of the period (in dollars per share) | $ 34.97 | $ 35.18 | $ 32.91 |
Exercised (in dollars per share) | 30.03 | 12.18 | |
Expired or forfeited (in dollars per share) | 36.21 | 37.47 | 34.44 |
Outstanding at the end of the period (in dollars per share) | $ 34.80 | $ 34.97 | $ 35.18 |
Stock Plans - Option Exercise R
Stock Plans - Option Exercise Ranges (Details) shares in Thousands | 12 Months Ended |
Dec. 31, 2018$ / sharesshares | |
Options Outstanding | |
Options Outstanding, Shares | shares | 1,222 |
Weighted Average Remaining Contractual Life | 3 years |
Weighted-Average Exercise Price (in dollars per share) | $ 34.80 |
Options Exercisable | |
Options Exercisable, Shares | shares | 1,222 |
Weighted Average Remaining Contractual life | 3 years |
Weighted Average Exercise Price (in dollars per share) | $ 34.80 |
$20.00 - $30.00 | |
Stock plans | |
Exercise price, low end of range (in dollars per share) | 20 |
Exercise price, high end of range (in dollars per share) | $ 30 |
Options Outstanding | |
Options Outstanding, Shares | shares | 25 |
Weighted Average Remaining Contractual Life | 3 years 7 months 6 days |
Weighted-Average Exercise Price (in dollars per share) | $ 28.13 |
Options Exercisable | |
Options Exercisable, Shares | shares | 25 |
Weighted Average Remaining Contractual life | 3 years 7 months 6 days |
Weighted Average Exercise Price (in dollars per share) | $ 28.13 |
$30.01 - $40.00 | |
Stock plans | |
Exercise price, low end of range (in dollars per share) | 30.01 |
Exercise price, high end of range (in dollars per share) | $ 40 |
Options Outstanding | |
Options Outstanding, Shares | shares | 1,058 |
Weighted Average Remaining Contractual Life | 3 years 1 month 6 days |
Weighted-Average Exercise Price (in dollars per share) | $ 32.81 |
Options Exercisable | |
Options Exercisable, Shares | shares | 1,058 |
Weighted Average Remaining Contractual life | 3 years 1 month 6 days |
Weighted Average Exercise Price (in dollars per share) | $ 32.81 |
$40.01 - $50.00 | |
Stock plans | |
Exercise price, low end of range (in dollars per share) | 40.01 |
Exercise price, high end of range (in dollars per share) | $ 50 |
Options Outstanding | |
Options Outstanding, Shares | shares | 12 |
Weighted Average Remaining Contractual Life | 1 year 8 months 12 days |
Weighted-Average Exercise Price (in dollars per share) | $ 45.57 |
Options Exercisable | |
Options Exercisable, Shares | shares | 12 |
Weighted Average Remaining Contractual life | 1 year 8 months 12 days |
Weighted Average Exercise Price (in dollars per share) | $ 45.57 |
$50.01 - $60.00 | |
Stock plans | |
Exercise price, low end of range (in dollars per share) | 50.01 |
Exercise price, high end of range (in dollars per share) | $ 60 |
Options Outstanding | |
Options Outstanding, Shares | shares | 127 |
Weighted Average Remaining Contractual Life | 2 years 4 months 24 days |
Weighted-Average Exercise Price (in dollars per share) | $ 51.70 |
Options Exercisable | |
Options Exercisable, Shares | shares | 127 |
Weighted Average Remaining Contractual life | 2 years 4 months 24 days |
Weighted Average Exercise Price (in dollars per share) | $ 51.70 |
Stock Plans - Options Exercised
Stock Plans - Options Exercised (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Stock Plans | ||
Cash received from options exercised | $ 431 | $ 494 |
Intrinsic value of options exercised | $ 51 | $ 1,165 |
Stock Plans - RSAs, RSUs, PSAs
Stock Plans - RSAs, RSUs, PSAs and PSUs (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
RSAs, RSUs, PSAs and PSUs | |||
Number of Shares | |||
Outstanding at the beginning of the period (in shares) | 1,880 | 1,949 | 1,398 |
Granted (in shares) | 1,257 | 674 | 1,166 |
Performance award adjustments (in shares) | (5) | (25) | |
Assumed from Ultratech (in shares) | 338 | ||
Vested (in shares) | (523) | (831) | (349) |
Forfeited (in shares) | (391) | (225) | (266) |
Outstanding at the end of the period (in shares) | 2,218 | 1,880 | 1,949 |
Weighted Average Grant Date Fair Value | |||
Outstanding at the beginning of the period (in dollars per share) | $ 25.41 | $ 23.85 | $ 31.97 |
Granted (in dollars per share) | 17.37 | 29.22 | 17.59 |
Performance award adjustments (in dollars per share) | 32.67 | 20.95 | |
Assumed from Ultratech (in dollars per share) | 31.75 | ||
Vested (in dollars per share) | 26.39 | 27.67 | 32.73 |
Forfeited (in dollars per share) | 24.66 | 26.29 | 27.31 |
Outstanding at the end of the period (in dollars per share) | $ 20.74 | $ 25.41 | $ 23.85 |
Total fair value of shares vested | $ 9.1 | $ 22.3 | $ 7.5 |
PSAs and PSUs | Minimum | |||
Weighted Average Grant Date Fair Value | |||
Vesting period | 1 year | ||
PSAs and PSUs | Maximum | |||
Weighted Average Grant Date Fair Value | |||
Vesting period | 5 years |
Stock Plans - RSAs, RSUs, PSA_2
Stock Plans - RSAs, RSUs, PSAs and PSUs FV Assumptions (Details) - RSAs, RSUs, PSAs and PSUs | 12 Months Ended |
Dec. 31, 2018$ / shares | |
Assumptions | |
Weighted average fair value (in dollars per share) | $ 15.58 |
Dividend yield (as a percent) | 0.00% |
Expected volatility factor (as a percent) | 49.00% |
Risk-free interest rate (as a percent) | 2.88% |
Expected life (in years) | 3 years |
Stock Plans - ESPP FV Assumptio
Stock Plans - ESPP FV Assumptions (Details) - ESPP - USD ($) $ / shares in Units, $ in Millions | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Share-based compensation | |||
Cash proceeds | $ 3.1 | $ 2.6 | $ 1.2 |
Number of shares issued | 332,096 | 163,000 | 83,000 |
Assumptions | |||
Weighted average fair value (in dollars per share) | $ 4.94 | $ 7.09 | $ 4.45 |
Dividend yield (as a percent) | 0.00% | 0.00% | 0.00% |
Expected volatility factor (as a percent) | 62.00% | 36.00% | 43.00% |
Risk-free interest rate (as a percent) | 1.81% | 0.99% | 0.35% |
Expected life (in years) | 6 months | 6 months | 6 months |
Retirement Plans - Defined Cont
Retirement Plans - Defined Contribution Plan (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Defined contribution plan disclosures | |||
Employer's matching contribution for every dollar the employees contribute (as a percent) | 50.00% | ||
Employer's matching contribution, vesting period (in years) | 5 years | ||
Aggregate employer's contribution to pension plans | $ 3 | $ 2.7 | $ 2.6 |
Maximum | |||
Defined contribution plan disclosures | |||
Employer's contribution as a percentage of employee's eligible compensation | 3.00% | ||
Employer's contribution as a percentage of the maximum an employee is permitted to contribute under IRS limits | 3.00% |
Retirement Plans - Defined Bene
Retirement Plans - Defined Benefit Plan (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Defined benefit plan disclosures | |||
Other income (expense), net | $ (368) | $ 392 | $ (223) |
Income tax expense (benefit) | $ (26,746) | $ (37,594) | 2,823 |
Minimum pension liability | Reclassification out of AOCI | |||
Defined benefit plan disclosures | |||
Other income (expense), net | (900) | ||
Income tax expense (benefit) | $ (400) |
Income Taxes - Income Attributa
Income Taxes - Income Attributable to Domestic and Foreign Operations (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Income (loss) from continuing operations before income taxes | |||
Domestic | $ (286,561) | $ (101,573) | $ (123,089) |
Foreign | (147,273) | 12,583 | 3,885 |
Income (loss) before income taxes | $ (433,834) | $ (88,990) | $ (119,204) |
Income Taxes - Components of Ex
Income Taxes - Components of Expense (Benefit) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Current: | |||
Federal | $ (1,682) | ||
Foreign | 2,518 | $ (2,246) | $ 1,937 |
State and local | 38 | 15 | (111) |
Total current expense (benefit) for income taxes | 874 | (2,231) | 1,826 |
Deferred: | |||
Federal | 205 | (35,912) | 1,459 |
Foreign | (27,932) | 1,291 | (589) |
State and local | 107 | (742) | 127 |
Total deferred expense (benefit) for income taxes | (27,620) | (35,363) | 997 |
Total expense (benefit) for income taxes | $ (26,746) | $ (37,594) | $ 2,823 |
Income Taxes - Reconciliation t
Income Taxes - Reconciliation to Statutory Tax Expense (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Income Taxes | |||
Income tax expense (benefit) at U.S. statutory rates | $ (91,105) | $ (31,147) | $ (41,722) |
State taxes, net of U.S. federal impact | (2,848) | (2,523) | (1,963) |
Effect of international operations | 11,847 | 10,158 | 8,798 |
Research and development tax credit | (2,230) | 620 | (801) |
Net change in valuation allowance | 7,747 | 1,883 | 50,544 |
Change in accrual for unrecognized tax benefits | 2,868 | (4,772) | (1,700) |
Subsidiary liquidation | (12,435) | ||
Share-based compensation | 1,848 | 99 | 2,133 |
Effect of 2017 Tax Act | 1,690 | 11,344 | |
Asset impairment | 46,872 | ||
Other | (55) | (568) | (31) |
Total expense (benefit) for income taxes | $ (26,746) | $ (37,594) | $ 2,823 |
Income Taxes - Additional discl
Income Taxes - Additional disclosure and 2017 Tax Act (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2018USD ($) | |
Income Taxes | |
Additional income tax benefit from effect of Tax Cuts and Jobs Act of 2017 | $ 1.7 |
2017 Tax Act, Amount of increase in gross deferred tax assets | 6.8 |
2017 Tax Act, Increase in deferred tax assets valuation allowance | $ 6.8 |
Income Taxes - Reduction of U.S
Income Taxes - Reduction of U.S. Corporate Tax Rate (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Income Taxes | ||
U.S. federal statutory rate (as a percent) | 21.00% | 35.00% |
Income tax benefit | $ (4.8) | |
Amount of reduction in net deferred tax assets | 25.6 | |
Reduction in valuation allowance | $ 30.4 |
Income Taxes - One-Time Transit
Income Taxes - One-Time Transition Tax (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2017USD ($) | |
Income Taxes | |
Accumulated undistributed earnings by foreign subsidiaries | $ 180.1 |
Income Taxes - Valuation Allowa
Income Taxes - Valuation Allowance (Details) - USD ($) $ in Millions | Jan. 01, 2018 | Dec. 31, 2017 |
Income Taxes | ||
Maximum NOL deduction in any year as percentage of taxable income | 80.00% | |
Income tax benefit related to valuation allowance | $ 6.5 |
Income Taxes - Deferred Taxes (
Income Taxes - Deferred Taxes (Details) - USD ($) $ in Thousands | Dec. 31, 2018 | Dec. 31, 2017 |
Deferred tax assets: | ||
Inventory valuation | $ 8,943 | $ 8,007 |
Net operating losses | 67,787 | 73,458 |
Credit carry forwards | 52,592 | 34,966 |
Warranty and installation accruals | 1,695 | 1,690 |
Share-based compensation | 6,981 | 7,385 |
Other | 2,182 | 1,832 |
Total deferred tax assets | 140,180 | 127,338 |
Valuation allowance | (114,955) | (100,456) |
Net deferred tax assets | 25,225 | 26,882 |
Deferred tax liabilities: | ||
Purchased intangible assets | 15,401 | 45,807 |
Convertible Senior Notes | 11,265 | 13,534 |
Depreciation | 2,380 | 1,339 |
Total deferred tax liabilities | 29,046 | 60,680 |
Net deferred taxes | (3,821) | $ (33,798) |
Undistributed earnings of foreign subsidiaries | ||
Undistributed earnings of foreign subsidiaries | $ 600 |
Income Taxes - Operating Loss C
Income Taxes - Operating Loss Carryforwards (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Operating loss carryforwards disclosures | ||
Net deferred tax asset | $ 67,787 | $ 73,458 |
Federal | ||
Operating loss carryforwards disclosures | ||
Net operating loss carryforwards | 281,400 | |
Net operating loss carryforwards, Indefinite carryforward period | 16,000 | |
Federal | Ultratech | ||
Operating loss carryforwards disclosures | ||
Net operating loss carryforwards | 119,000 | |
State and local | ||
Operating loss carryforwards disclosures | ||
Net operating loss carryforwards | 147,600 | |
Net deferred tax asset | $ 9,000 |
Income Taxes - Tax Credit Carry
Income Taxes - Tax Credit Carryforwards (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2018USD ($) | |
Valuation allowance | |
Increase (decrease) in valuation allowance | $ 14.5 |
2017 Tax Act, Increase in deferred tax assets valuation allowance | 6.8 |
Federal | Capital loss carryforward | |
Tax credit carryforward | |
Tax credit carry forwards | 3.5 |
Federal | Research and development tax credit carryforward | |
Tax credit carryforward | |
Tax credit carry forwards | 28.3 |
Federal | Research and development tax credit carryforward | Ultratech | |
Tax credit carryforward | |
Tax credit carry forwards | 11.4 |
State and local | |
Tax credit carryforward | |
Tax credit carry forwards | 27.4 |
Foreign tax | |
Tax credit carryforward | |
Tax credit carry forwards | $ 9.4 |
Income Taxes - Uncertain Tax Po
Income Taxes - Uncertain Tax Positions (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Change in unrecognized tax benefits | |||
Balance at beginning of year | $ 8,269 | $ 7,452 | $ 9,152 |
Additions for tax positions related to current year | 2,154 | 511 | 1,038 |
Additions for tax positions relating to prior years | 1,721 | 3 | 233 |
Reductions for tax positions relating to prior years | (934) | (4,877) | (2,826) |
Reductions due to the lapse of the applicable statute of limitations | (26) | (122) | (39) |
Settlements | (47) | (287) | (106) |
Additions for business combination | 5,589 | ||
Balance at end of year | 11,137 | 8,269 | $ 7,452 |
Unrecognized tax benefits that would impact effective tax rate if recognized | 1,500 | ||
Accrued interest and penalties related to unrecognized tax benefits | $ 300 | $ 300 |
Segment Reporting and Geograp_3
Segment Reporting and Geographic Information - Segment (Details) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2018USD ($) | Sep. 30, 2018USD ($) | Jun. 30, 2018USD ($) | Mar. 31, 2018USD ($) | Dec. 31, 2017USD ($) | Sep. 30, 2017USD ($) | Jun. 30, 2017USD ($) | Mar. 31, 2017USD ($) | Dec. 31, 2018USD ($)segment | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | |
Revenue reporting by end-market and geographic region | |||||||||||
Number of operating segments | segment | 1 | ||||||||||
Number of reportable segments | segment | 1 | ||||||||||
Net sales | $ 98,972 | $ 126,757 | $ 157,779 | $ 158,574 | $ 139,661 | $ 129,308 | $ 112,218 | $ 94,499 | $ 542,082 | $ 475,686 | $ 331,702 |
Advanced Packaging, MEMS & RF Filters | |||||||||||
Revenue reporting by end-market and geographic region | |||||||||||
Net sales | 90,775 | 67,406 | 67,484 | ||||||||
LED Lighting, Display & Compound Semiconductor | |||||||||||
Revenue reporting by end-market and geographic region | |||||||||||
Net sales | 249,974 | 248,615 | 145,701 | ||||||||
Front-End Semiconductor | |||||||||||
Revenue reporting by end-market and geographic region | |||||||||||
Net sales | 62,582 | 40,319 | 8,427 | ||||||||
Scientific & Industrial | |||||||||||
Revenue reporting by end-market and geographic region | |||||||||||
Net sales | $ 138,751 | $ 119,346 | $ 110,090 |
Segment Reporting and Geograp_4
Segment Reporting and Geographic Information - Geographic (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2018 | Sep. 30, 2018 | Jun. 30, 2018 | Mar. 31, 2018 | Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Revenue reporting by end-market and geographic region | |||||||||||
Net sales | $ 98,972 | $ 126,757 | $ 157,779 | $ 158,574 | $ 139,661 | $ 129,308 | $ 112,218 | $ 94,499 | $ 542,082 | $ 475,686 | $ 331,702 |
Long-lived Tangible Assets | 80,284 | 85,058 | 80,284 | 85,058 | 60,646 | ||||||
United States | |||||||||||
Revenue reporting by end-market and geographic region | |||||||||||
Net sales | 125,659 | 93,433 | 85,582 | ||||||||
Long-lived Tangible Assets | 78,503 | 81,046 | 78,503 | 81,046 | 60,012 | ||||||
China | |||||||||||
Revenue reporting by end-market and geographic region | |||||||||||
Net sales | 194,032 | 106,674 | 84,604 | ||||||||
Long-lived Tangible Assets | 81 | 64 | 81 | 64 | 219 | ||||||
EMEA | |||||||||||
Revenue reporting by end-market and geographic region | |||||||||||
Net sales | 89,102 | 72,979 | 84,181 | ||||||||
Long-lived Tangible Assets | 205 | 231 | 205 | 231 | 93 | ||||||
Rest Of World | |||||||||||
Revenue reporting by end-market and geographic region | |||||||||||
Net sales | 133,289 | 202,600 | 77,335 | ||||||||
Long-lived Tangible Assets | $ 1,495 | $ 3,717 | $ 1,495 | $ 3,717 | $ 322 |
Selected Quarterly Financial _3
Selected Quarterly Financial Information (unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2018 | Sep. 30, 2018 | Jun. 30, 2018 | Mar. 31, 2018 | Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Quarterly Financial Information | |||||||||||
Net sales | $ 98,972 | $ 126,757 | $ 157,779 | $ 158,574 | $ 139,661 | $ 129,308 | $ 112,218 | $ 94,499 | $ 542,082 | $ 475,686 | $ 331,702 |
Gross profit | 35,259 | 46,385 | 55,395 | 56,680 | 55,352 | 50,529 | 35,847 | 34,500 | 193,719 | 176,228 | 133,098 |
Net income (loss) | $ (144,674) | $ (8,953) | $ (237,634) | $ (15,827) | $ (8,479) | $ (23,740) | $ (20,817) | $ 1,640 | $ (407,088) | $ (51,396) | $ (122,027) |
Basic income (loss) per common share (in dollars per share) | $ (3.11) | $ (0.19) | $ (5.02) | $ (0.34) | $ (0.18) | $ (0.51) | $ (0.49) | $ 0.04 | $ (8.63) | $ (1.16) | $ (3.10) |
Diluted earnings (loss) per share (in dollars per share) | $ (3.11) | $ (0.19) | $ (5.02) | $ (0.34) | $ (0.18) | $ (0.51) | $ (0.49) | $ 0.04 | $ (8.63) | $ (1.16) | $ (3.10) |
Selected Quarterly Financial _4
Selected Quarterly Financial Information (unaudited) - Impairments (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Jun. 30, 2018 | Dec. 31, 2018 | |
Future investments | ||
Impairment charges, Definite-lived intangible assets | $ 216,400 | |
Impairment | $ 122,829 | |
In-process R&D | ||
Future investments | ||
Impairment charges, Indefinite-lived intangible assets | $ 35,900 |
Schedule II - Valuation and Q_2
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Valuation and Qualifying Accounts | |||
Balance at Beginning of Period | $ 100,726 | $ 105,030 | $ 54,406 |
Charged (Credited) to Costs and Expenses | 14,499 | (49,490) | 50,715 |
Charged to Other Accounts | 45,301 | ||
Deductions | (115) | (91) | |
Balance at End of Period | 115,225 | 100,726 | 105,030 |
Allowance for doubtful accounts | |||
Valuation and Qualifying Accounts | |||
Balance at Beginning of Period | 270 | 286 | 206 |
Charged (Credited) to Costs and Expenses | 99 | 171 | |
Deductions | (115) | (91) | |
Balance at End of Period | 270 | 270 | 286 |
Valuation allowance in net deferred tax assets | |||
Valuation and Qualifying Accounts | |||
Balance at Beginning of Period | 100,456 | 104,744 | 54,200 |
Charged (Credited) to Costs and Expenses | 14,499 | (49,589) | 50,544 |
Charged to Other Accounts | 45,301 | ||
Balance at End of Period | $ 114,955 | $ 100,456 | $ 104,744 |